{ "@context": "https://schema.org", "@type": "ItemList", "name": "Akuma Enterprise Pharma \u2014 Commercial Finished Pharmaceutical Formulations & Peptide Portfolio", "description": "Directory of 224 WHO-GMP certified commercial finished pharmaceutical formulations, Peptide APIs, and Research Peptides (RUO) across 12 product categories and 15 therapeutic sectors exported by Akuma Enterprise Pharma to Africa and global markets.", "numberOfItems": 224, "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@type": [ "Product", "Drug" ], "name": "Ofloxacin 200mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/ofloxacin-200mg-tablets-akp-001", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-001-ofloxacin-200mg-tablets.webp", "description": "Broad-spectrum second-generation fluoroquinolone antibacterial tablet engineered for rapid oral bioavailability and consistent dissolution across uncomplicated respiratory, urinary, and soft-tissue bacterial infections. Active: Ofloxacin IP (200 mg). Indication: Urinary tract infections (UTI), acute bacterial bronchitis, pneumonia, and uncomplicated gonorrhea.", "sku": "AKP-001", "category": "Tablets \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Ofloxacin IP", "strength": "200 mg" } }, { "@type": "ListItem", "position": 2, "item": { "@type": [ "Product", "Drug" ], "name": "Leuprorelin Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/leuprorelin-acetate-peptide-api-akp-api-01", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-01-leuprorelin-acetate.webp", "description": "GnRH agonist decapeptide API for sustained pituitary desensitization and androgen/estrogen suppression depot formulations. Indicated for Prostate cancer, Breast cancer. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 74381-53-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Leuprorelin Acetate (CAS 74381-53-6) (Purity \u2265 99.0% (HPLC)). Indication: Prostate cancer, Breast cancer.", "sku": "AKP-API-01", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Leuprorelin Acetate (CAS 74381-53-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "74381-53-6" } }, { "@type": "ListItem", "position": 3, "item": { "@type": [ "Product", "Drug" ], "name": "Cefoperazone Sodium 500mg & Sulbactam Sodium 500mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/cefoperazone-sodium-500mg-sulbactam-sodium-500mg-injection-akp-041", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-041-cefoperazone-sodium-500mg-sulbactam-sodi.webp", "description": "Hospital-grade third-generation antipseudomonal cephalosporin paired 1:1 with beta-lactamase inhibitor sulbactam in a sterile glass vial for critical-care parenteral infection control. Active: Cefoperazone Sodium USP (eq. 500 mg) + Sulbactam Sodium USP (eq. 500 mg) (500 mg + 500 mg (1 g)). Indication: Severe nosocomial sepsis, hospital-acquired pneumonia, intra-abdominal infections, and Pseudomonas/ESBL infections.", "sku": "AKP-041", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Cefoperazone Sodium USP (eq. 500 mg) + Sulbactam Sodium USP (eq. 500 mg)", "strength": "500 mg + 500 mg (1 g)" } }, { "@type": "ListItem", "position": 4, "item": { "@type": [ "Product", "Drug" ], "name": "Magaldrate 400mg & Simethicone 20mg Oral Suspension (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/magaldrate-400mg-simethicone-20mg-oral-suspension-per-5ml-akp-031", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-031-magaldrate-400mg-simethicone-20mg-oral-s.webp", "description": "Sugar-free smooth-textured hydroxymagnesium aluminate antacid and antiflatulent oral suspension delivering rapid acid buffering and gas bubble dispersion without rebound hyperacidity. Active: Magaldrate IP 400 mg + Simethicone IP 20 mg (per 5 ml) (400 mg + 20 mg / 5 ml). Indication: Heartburn, acid indigestion, flatulence, hiatal hernia reflux, and peptic ulcer symptom relief.", "sku": "AKP-031", "category": "Oral Liquids \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Liquid Suspension", "activeIngredient": "Magaldrate IP 400 mg + Simethicone IP 20 mg (per 5 ml)", "strength": "400 mg + 20 mg / 5 ml" } }, { "@type": "ListItem", "position": 5, "item": { "@type": [ "Product", "Drug" ], "name": "Omeprazole 20mg Capsules (Enteric Coated Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/omeprazole-20mg-capsules-enteric-coated-pellets-akp-011", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-011-omeprazole-20mg-capsules-enteric-coated.webp", "description": "Hard gelatin capsule filled with acid-resistant enteric-coated omeprazole pellets to ensure uniform gastric bypass and reliable duodenal absorption in acid-peptic disorders. Active: Omeprazole IP (as Enteric-Coated Pellets) (20 mg). Indication: Peptic ulcer disease, GERD, maintenance of healed erosive esophagitis, and acid hypersecretion.", "sku": "AKP-011", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Pellet Capsules", "activeIngredient": "Omeprazole IP (as Enteric-Coated Pellets)", "strength": "20 mg" } }, { "@type": "ListItem", "position": 6, "item": { "@type": [ "Product", "Drug" ], "name": "Fluticasone Furoate 0.0275% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/fluticasone-furoate-0-0275-w-v-nasal-spray-akp-071", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-071-fluticasone-furoate-0-0275-w-v-nasal-spr.webp", "description": "High-affinity corticosteroid fine-mist nasal spray providing 24-hour suppression of nasal congestion, rhinorrhea, and ocular allergy symptoms with ultra-low systemic bioavailability. Active: Fluticasone Furoate 0.0275% w/v (0.0275% w/v (27.5 mcg/spray)). Indication: Seasonal and perennial allergic rhinitis in adults and children aged 2+ years.", "sku": "AKP-071", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Metered-Dose Nasal Spray", "activeIngredient": "Fluticasone Furoate 0.0275% w/v", "strength": "0.0275% w/v (27.5 mcg/spray)" } }, { "@type": "ListItem", "position": 7, "item": { "@type": [ "Product", "Drug" ], "name": "Terbinafine Cream 1.0%", "url": "https://www.akumaenterprises-pharma.com/product/terbinafine-cream-1-0-akp-021", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-021-terbinafine-cream-1-0.webp", "description": "Fungicidal allylamine dermatological cream inhibiting fungal squalene epoxidase for rapid dermal clearance and shorter topical treatment courses against dermatophytes. Active: Terbinafine Hydrochloride IP 1.0% w/w (1.0% w/w). Indication: Tinea pedis (athlete's foot), tinea cruris, tinea corporis, and cutaneous candidiasis.", "sku": "AKP-021", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Terbinafine Hydrochloride IP 1.0% w/w", "strength": "1.0% w/w" } }, { "@type": "ListItem", "position": 8, "item": { "@type": [ "Product", "Drug" ], "name": "Amikacin Sulphate 100mg Injection (per 2ml)", "url": "https://www.akumaenterprises-pharma.com/product/amikacin-sulphate-100mg-injection-per-2ml-akp-051", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-051-amikacin-sulphate-100mg-injection-per-2m.webp", "description": "Ready-to-use neonatal/paediatric strength 100 mg/2 ml aminoglycoside sterile solution engineered with strict bacterial endotoxin limits for critical gram-negative infections. Active: Amikacin Sulphate IP (eq. Amikacin 100 mg per 2 ml) (100 mg / 2 ml). Indication: Neonatal sepsis, paediatric serious gram-negative bacteremia, and gentamicin-resistant UTI.", "sku": "AKP-051", "category": "Liquid Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Vial / Ampoule", "activeIngredient": "Amikacin Sulphate IP (eq. Amikacin 100 mg per 2 ml)", "strength": "100 mg / 2 ml" } }, { "@type": "ListItem", "position": 9, "item": { "@type": [ "Product", "Drug" ], "name": "Moxifloxacin 0.5% w/v Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/moxifloxacin-0-5-w-v-eye-drops-akp-061", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-061-moxifloxacin-0-5-w-v-eye-drops.webp", "description": "Preservative-optimized fourth-generation fluoroquinolone sterile eye drops delivering rapid corneal penetration and potent eradication of both gram-positive and gram-negative ocular pathogens. Active: Moxifloxacin Hydrochloride IP (eq. Moxifloxacin 0.5% w/v) (0.5% w/v). Indication: Bacterial conjunctivitis, corneal ulceration, and post-cataract surgical endophthalmitis prophylaxis.", "sku": "AKP-061", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Ophthalmic Solution", "activeIngredient": "Moxifloxacin Hydrochloride IP (eq. Moxifloxacin 0.5% w/v)", "strength": "0.5% w/v" } }, { "@type": "ListItem", "position": 10, "item": { "@type": [ "Product", "Drug" ], "name": "Cyproheptadine Hydrochloride 2mg & Tricholine Citrate (65%) 55mg Drops (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/cyproheptadine-hydrochloride-2mg-tricholine-citrate-65-55mg-akp-085", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-085-cyproheptadine-hydrochloride-2mg-trichol.webp", "description": "Micro-volume paediatric appetite-stimulating oral drops combining mild orexigenic cyproheptadine with lipotropic tricholine citrate for failure-to-thrive nutrition support. Active: Cyproheptadine Hydrochloride IP 2 mg + Tricholine Citrate (65%) 55 mg (per ml) (2 mg + 55 mg / ml). Indication: Infant & toddler anorexia, poor weight gain, post-illness appetite recovery, and hepatic support.", "sku": "AKP-085", "category": "Drops \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Calibrated Paediatric Oral Drops", "activeIngredient": "Cyproheptadine Hydrochloride IP 2 mg + Tricholine Citrate (65%) 55 mg (per ml)", "strength": "2 mg + 55 mg / ml" } }, { "@type": "ListItem", "position": 11, "item": { "@type": [ "Product", "Drug" ], "name": "Cefixime 50mg Dry Syrup (per 5ml Reconstituted Suspension)", "url": "https://www.akumaenterprises-pharma.com/product/cefixime-50mg-dry-syrup-per-5ml-reconstituted-suspension-akp-081", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-081-cefixime-50mg-dry-syrup-per-5ml-reconsti.webp", "description": "Palatable fruit-flavoured paediatric third-generation cephalosporin dry powder for oral suspension engineered for smooth homogenous reconstitution and accurate weight-based dosing. Active: Cefixime IP (as Trihydrate, eq. Anhydrous Cefixime 50 mg / 5 ml) (50 mg / 5 ml). Indication: Paediatric enteric typhoid fever, acute otitis media, pharyngitis, tonsillitis, and pediatric UTI.", "sku": "AKP-081", "category": "Dry Syrup \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Dry Syrup (Oral Suspension)", "activeIngredient": "Cefixime IP (as Trihydrate, eq. Anhydrous Cefixime 50 mg / 5 ml)", "strength": "50 mg / 5 ml" } }, { "@type": "ListItem", "position": 12, "item": { "@type": [ "Product", "Drug" ], "name": "Isopropyl Alcohol IP 70% v/v Gel Base Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/isopropyl-alcohol-ip-70-v-v-gel-base-sanitizer-akp-087", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-087-isopropyl-alcohol-ip-70-v-v-gel-base-san.webp", "description": "No-rinse hospital-grade 70% isopropyl alcohol carbomer gel sanitizer enriched with skin-conditioning humectants for frequent ICU, ward, and laboratory hand disinfection. Active: Isopropyl Alcohol IP 70% v/v + Emollient Carbomer Gel Base (70% v/v Isopropyl Alcohol). Indication: Clinical hand hygiene, rapid broad-spectrum bactericidal, virucidal, and fungicidal hand antisepsis.", "sku": "AKP-087", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Antiseptic Hand Sanitizer Gel", "activeIngredient": "Isopropyl Alcohol IP 70% v/v + Emollient Carbomer Gel Base", "strength": "70% v/v Isopropyl Alcohol" } }, { "@type": "ListItem", "position": 13, "item": { "@type": [ "Product", "Drug" ], "name": "Levocetirizine Hydrochloride 5mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/levocetirizine-hydrochloride-5mg-tablets-akp-003", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-003-levocetirizine-hydrochloride-5mg-tablets.webp", "description": "Third-generation non-sedating H1-receptor antagonist film-coated tablet providing 24-hour histamine blockade for rapid relief of sneezing, rhinorrhea, nasal pruritus, and chronic hives. Active: Levocetirizine Hydrochloride IP (5 mg). Indication: Perennial and seasonal allergic rhinitis, chronic idiopathic urticaria, and allergic conjunctivitis.", "sku": "AKP-003", "category": "Tablets \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Levocetirizine Hydrochloride IP", "strength": "5 mg" } }, { "@type": "ListItem", "position": 14, "item": { "@type": "Product", "name": "Retatrutide Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/retatrutide-research-peptide-akp-rp-01", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-01-retatrutide.webp", "description": "Triple GLP-1/GIP/glucagon receptor agonist research peptide supplied for preclinical metabolic and adiposity assay investigations. Research area: Obesity and metabolic. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 2381089-83-2) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Retatrutide (CAS 2381089-83-2) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Obesity and metabolic.", "sku": "AKP-RP-01", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "2381089-83-2" } }, { "@type": "ListItem", "position": 15, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 30 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-30-mg-akp-004-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-004-artesunate-30mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (30 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 30 mg (30 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-004-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 30 mg", "strength": "30 mg" } }, { "@type": "ListItem", "position": 16, "item": { "@type": [ "Product", "Drug" ], "name": "Terbutaline Sulphate 1.25mg, Bromhexine HCl 2mg, Guaiphenesin 50mg & Menthol 0.5mg Syrup (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/terbutaline-sulphate-1-25mg-bromhexine-hcl-2mg-guaiphenesin-akp-032", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-032-terbutaline-sulphate-1-25mg-bromhexine-h.webp", "description": "Quadruple-action bronchodilator and mucolytic expectorant syrup combining beta-2 smooth muscle relaxation, mucus viscosity cleavage, ciliary clearance, and soothing menthol cooling. Active: Terbutaline Sulphate IP 1.25 mg + Bromhexine HCl IP 2 mg + Guaiphenesin IP 50 mg + Menthol IP 0.5 mg (1.25 mg + 2 mg + 50 mg + 0.5 mg / 5 ml). Indication: Productive cough associated with acute bronchitis, asthma, and COPD mucus hypersecretion.", "sku": "AKP-032", "category": "Oral Liquids \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Expectorant Syrup", "activeIngredient": "Terbutaline Sulphate IP 1.25 mg + Bromhexine HCl IP 2 mg + Guaiphenesin IP 50 mg + Menthol IP 0.5 mg", "strength": "1.25 mg + 2 mg + 50 mg + 0.5 mg / 5 ml" } }, { "@type": "ListItem", "position": 17, "item": { "@type": [ "Product", "Drug" ], "name": "Itraconazole 100mg Capsules (Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/itraconazole-100mg-capsules-pellets-akp-017", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-017-itraconazole-100mg-capsules-pellets.webp", "description": "Triazole antifungal capsule utilizing solid-dispersion sugar-sphere pellet technology to overcome poor aqueous solubility and maximize systemic absorption in dermatophytic and deep mycoses. Active: Itraconazole BP / IP 100 mg (Pelletized) (100 mg). Indication: Onychomycosis, systemic candidiasis, tinea corporis, histoplasmosis, and sporotrichosis.", "sku": "AKP-017", "category": "Capsules \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Supra-Bioavailable Pellet Capsules", "activeIngredient": "Itraconazole BP / IP 100 mg (Pelletized)", "strength": "100 mg" } }, { "@type": "ListItem", "position": 18, "item": { "@type": [ "Product", "Drug" ], "name": "Calcitonin (Salmon) 2200 IU Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/calcitonin-salmon-2200-iu-nasal-spray-akp-073", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-073-calcitonin-salmon-2200-iu-nasal-spray.webp", "description": "Intranasal polypeptide calcium-regulating spray inhibiting osteoclastic bone resorption and providing centrally mediated analgesia in painful osteoporotic vertebral compression fractures. Active: Calcitonin (Salmon) Synthetic BP / USP 2200 IU/ml (2200 IU/ml (200 IU/spray)). Indication: Postmenopausal osteoporosis pain & vertebral bone loss, Paget's bone disease, and hypercalcemia.", "sku": "AKP-073", "category": "Nasal Spray \u2014 Endocrine & Supportive Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Metered-Dose Peptide Nasal Spray", "activeIngredient": "Calcitonin (Salmon) Synthetic BP / USP 2200 IU/ml", "strength": "2200 IU/ml (200 IU/spray)" } }, { "@type": "ListItem", "position": 19, "item": { "@type": [ "Product", "Drug" ], "name": "Diclofenac 1.0%, Linseed Oil 3.0%, Methyl Salicylate 10%, Menthol 5.0% & Benzyl Alcohol 1.0% Gel", "url": "https://www.akumaenterprises-pharma.com/product/diclofenac-1-0-linseed-oil-3-0-methyl-salicylate-10-menthol-akp-024", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-024-diclofenac-1-0-linseed-oil-3-0-methyl-sa.webp", "description": "Rapid-penetration transdermal rubefacient pain-relief gel combining deep NSAID prostaglandin suppression with cooling menthol and warming methyl salicylate vasodilation. Active: Diclofenac Diethylamine (eq. Diclofenac 1.0%) + Linseed Oil 3.0% + Methyl Salicylate 10.0% + Menthol 5.0% + Benzyl Alcohol 1.0% (1.0% / 3.0% / 10% / 5.0% / 1.0% w/w). Indication: Sprains, strains, osteoarthritis knee pain, myofascial spasm, and sports soft-tissue injuries.", "sku": "AKP-024", "category": "Ointments & Creams \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Analgesic Gel", "activeIngredient": "Diclofenac Diethylamine (eq. Diclofenac 1.0%) + Linseed Oil 3.0% + Methyl Salicylate 10.0% + Menthol 5.0% + Benzyl Alcohol 1.0%", "strength": "1.0% / 3.0% / 10% / 5.0% / 1.0% w/w" } }, { "@type": "ListItem", "position": 20, "item": { "@type": [ "Product", "Drug" ], "name": "Diclofenac Sodium 75mg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/diclofenac-sodium-75mg-injection-per-ml-akp-054", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-054-diclofenac-sodium-75mg-injection-per-ml.webp", "description": "Low-viscosity aqueous/solubilized 1 ml high-concentration NSAID injection formulated for painless deep intragluteal IM or diluted IV analgesia in emergency trauma rooms. Active: Diclofenac Sodium IP 75 mg (per 1 ml aqueous base) (75 mg / 1 ml). Indication: Acute renal colic, biliary colic, post-operative severe pain, acute gout flare, and orthopedic trauma.", "sku": "AKP-054", "category": "Liquid Injections \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Ampoule", "activeIngredient": "Diclofenac Sodium IP 75 mg (per 1 ml aqueous base)", "strength": "75 mg / 1 ml" } }, { "@type": "ListItem", "position": 21, "item": { "@type": [ "Product", "Drug" ], "name": "Paradichlorobenzene 2%, Benzocaine 2.7%, Chlorbutol 5% & Turpentine Oil 15% Ear Drops", "url": "https://www.akumaenterprises-pharma.com/product/paradichlorobenzene-2-benzocaine-2-7-chlorbutol-5-turpentine-akp-062", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-062-paradichlorobenzene-2-benzocaine-2-7-chl.webp", "description": "Complete ceruminolytic otic formulation softening hardened impacted earwax while benzocaine and chlorbutol provide gentle canal analgesia and antimicrobial preservation. Active: Paradichlorobenzene 2.0% + Benzocaine 2.7% + Chlorbutol 5.0% + Turpentine Oil 15.0% w/v (2% + 2.7% + 5% + 15% w/v). Indication: Impacted earwax (cerumen) softening and ear canal discomfort prior to syringing.", "sku": "AKP-062", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Otic Ear Drops", "activeIngredient": "Paradichlorobenzene 2.0% + Benzocaine 2.7% + Chlorbutol 5.0% + Turpentine Oil 15.0% w/v", "strength": "2% + 2.7% + 5% + 15% w/v" } }, { "@type": "ListItem", "position": 22, "item": { "@type": [ "Product", "Drug" ], "name": "Dicyclomine Hydrochloride 10mg & Activated Dimethicone 40mg Drops (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/dicyclomine-hydrochloride-10mg-activated-dimethicone-40mg-dr-akp-086", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-086-dicyclomine-hydrochloride-10mg-activated.webp", "description": "Antispasmodic and antiflatulent paediatric oral drops combining direct anticholinergic bowel-spasm relaxation with surface-active gas bubble coalescence. Active: Dicyclomine Hydrochloride IP 10 mg + Activated Dimethicone (Simethicone) IP 40 mg (per ml) (10 mg + 40 mg / ml). Indication: Infantile smooth-muscle intestinal colic, abdominal griping pain, and trapped gas flatulence (>6 months).", "sku": "AKP-086", "category": "Drops \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Anti-Colic Oral Drops", "activeIngredient": "Dicyclomine Hydrochloride IP 10 mg + Activated Dimethicone (Simethicone) IP 40 mg (per ml)", "strength": "10 mg + 40 mg / ml" } }, { "@type": "ListItem", "position": 23, "item": { "@type": [ "Product", "Drug" ], "name": "Cefixime 100mg Dry Syrup (per 5ml Reconstituted Suspension)", "url": "https://www.akumaenterprises-pharma.com/product/cefixime-100mg-dry-syrup-per-5ml-reconstituted-suspension-akp-082", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-082-cefixime-100mg-dry-syrup-per-5ml-reconst.webp", "description": "Double-strength 100 mg/5 ml paediatric oral cephalosporin dry syrup enabling smaller per-dose volumes in older children battling systemic bacterial infections. Active: Cefixime IP (as Trihydrate, eq. Anhydrous Cefixime 100 mg / 5 ml) (100 mg / 5 ml). Indication: High-dose paediatric multidrug-resistant typhoid, bronchitis, pneumonia, and pyelonephritis.", "sku": "AKP-082", "category": "Dry Syrup \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric High-Strength Dry Syrup", "activeIngredient": "Cefixime IP (as Trihydrate, eq. Anhydrous Cefixime 100 mg / 5 ml)", "strength": "100 mg / 5 ml" } }, { "@type": "ListItem", "position": 24, "item": { "@type": [ "Product", "Drug" ], "name": "Isopropyl Alcohol IP 70% v/v Rub Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/isopropyl-alcohol-ip-70-v-v-rub-sanitizer-akp-088", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-088-isopropyl-alcohol-ip-70-v-v-rub-sanitize.webp", "description": "Fast-evaporating liquid antiseptic hand rub complying with compendial 70% IPA bactericidal strength for rapid pathogen kill without sticky residue. Active: Isopropyl Alcohol IP 70% v/v (Liquid Hand Rub) (70% v/v Isopropyl Alcohol). Indication: Ward-level rapid surgical and hygienic hand disinfection and minor surface skin antisepsis.", "sku": "AKP-088", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Clinical Antiseptic Hand Rub Solution", "activeIngredient": "Isopropyl Alcohol IP 70% v/v (Liquid Hand Rub)", "strength": "70% v/v Isopropyl Alcohol" } }, { "@type": "ListItem", "position": 25, "item": { "@type": [ "Product", "Drug" ], "name": "Aceclofenac 100mg & Paracetamol 325mg Tablets (Film Coated)", "url": "https://www.akumaenterprises-pharma.com/product/aceclofenac-100mg-paracetamol-325mg-tablets-film-coated-akp-004", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-004-aceclofenac-100mg-paracetamol-325mg-tabl.webp", "description": "Synergistic analgesic, anti-inflammatory, and antipyretic film-coated tablet combining selective COX-2 inhibition with central analgesia for acute musculoskeletal pain, joint stiffness, and post-operative recovery. Active: Aceclofenac IP + Paracetamol IP (100 mg + 325 mg). Indication: Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, and post-traumatic musculoskeletal inflammation.", "sku": "AKP-004", "category": "Tablets \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Aceclofenac IP + Paracetamol IP", "strength": "100 mg + 325 mg" } }, { "@type": "ListItem", "position": 26, "item": { "@type": [ "Product", "Drug" ], "name": "Semaglutide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/semaglutide-peptide-api-akp-api-02", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-02-semaglutide.webp", "description": "Long-acting GLP-1 receptor agonist peptide API for commercial glycemic control and chronic weight-management formulations. Indicated for T2DM, Obesity. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 910463-68-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Semaglutide (CAS 910463-68-2) (Purity \u2265 99.0% (HPLC)). Indication: T2DM, Obesity.", "sku": "AKP-API-02", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Semaglutide (CAS 910463-68-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "910463-68-2" } }, { "@type": "ListItem", "position": 27, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftazidime Pentahydrate 1000mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftazidime-pentahydrate-1000mg-injection-akp-042", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-042-ceftazidime-pentahydrate-1000mg-injectio.webp", "description": "High-potency sterile third-generation antipseudomonal cephalosporin dry powder vial engineered in ISO Class 5 suites for ICU gram-negative systemic infections. Active: Ceftazidime Pentahydrate USP / IP (eq. Anhydrous Ceftazidime 1000 mg) (1000 mg (1 g)). Indication: Pseudomonas aeruginosa bacteremia, febrile neutropenia, meningitis, and hospital pneumonia.", "sku": "AKP-042", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftazidime Pentahydrate USP / IP (eq. Anhydrous Ceftazidime 1000 mg)", "strength": "1000 mg (1 g)" } }, { "@type": "ListItem", "position": 28, "item": { "@type": [ "Product", "Drug" ], "name": "Cyproheptadine HCl 2mg & Tricholine Citrate 275mg Syrup (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/cyproheptadine-hcl-2mg-tricholine-citrate-275mg-syrup-per-5m-akp-033", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-033-cyproheptadine-hcl-2mg-tricholine-citrat.webp", "description": "Orexigenic H1/5-HT2 antagonist and lipotropic bile-acid binder oral syrup formulated to stimulate physiological appetite while supporting hepatic fatty-acid clearance. Active: Cyproheptadine Hydrochloride IP 2 mg + Tricholine Citrate 275 mg (2 mg + 275 mg / 5 ml). Indication: Loss of appetite, anorexia, underweight convalescence, and impaired hepatic lipid metabolism.", "sku": "AKP-033", "category": "Oral Liquids \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Appetite & Hepatotonic Syrup", "activeIngredient": "Cyproheptadine Hydrochloride IP 2 mg + Tricholine Citrate 275 mg", "strength": "2 mg + 275 mg / 5 ml" } }, { "@type": "ListItem", "position": 29, "item": { "@type": [ "Product", "Drug" ], "name": "Becosules Capsules (Vitamin B-Complex with Vitamin C & Zinc)", "url": "https://www.akumaenterprises-pharma.com/product/becosules-capsules-vitamin-b-complex-with-vitamin-c-zinc-akp-096", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-096-becosules-capsules-vitamin-b-complex-wit.webp", "description": "High-potency therapeutic water-soluble vitamin B-complex, vitamin C 150 mg, and zinc hard gelatin capsules engineered for tissue repair, oral ulcer healing, and post-antibiotic recovery. Active: Thiamine Mononitrate, Riboflavin, Pyridoxine HCl, B12, Niacinamide, Calcium Pantothenate, Folic Acid, Ascorbic Acid, Zinc (High-potency Therapeutic B-Complex + 150mg Vit C + Zinc). Indication: Mouth ulcers, convalescence, nutritional deficiency, post-antibiotic recovery.", "sku": "AKP-096", "category": "Capsules \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Thiamine Mononitrate, Riboflavin, Pyridoxine HCl, B12, Niacinamide, Calcium Pantothenate, Folic Acid, Ascorbic Acid, Zinc", "strength": "High-potency Therapeutic B-Complex + 150mg Vit C + Zinc" } }, { "@type": "ListItem", "position": 30, "item": { "@type": [ "Product", "Drug" ], "name": "Zolmitriptan 5.0% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/zolmitriptan-5-0-w-v-nasal-spray-akp-074", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-074-zolmitriptan-5-0-w-v-nasal-spray.webp", "description": "Fast-acting selective 5-HT1B/1D agonist intranasal spray bypassing gastric stasis during migraine nausea to achieve headache relief within 15 minutes via direct nasopharyngeal absorption. Active: Zolmitriptan 5.0% w/v (5 mg per 0.1 ml actuation) (5.0% w/v (5 mg/spray)). Indication: Acute migraine attacks with or without aura and cluster headaches requiring rapid non-oral onset.", "sku": "AKP-074", "category": "Nasal Spray \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Metered-Dose Anti-Migraine Nasal Spray", "activeIngredient": "Zolmitriptan 5.0% w/v (5 mg per 0.1 ml actuation)", "strength": "5.0% w/v (5 mg/spray)" } }, { "@type": "ListItem", "position": 31, "item": { "@type": [ "Product", "Drug" ], "name": "Clobetasol Cream 0.05%", "url": "https://www.akumaenterprises-pharma.com/product/clobetasol-cream-0-05-akp-022", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-022-clobetasol-cream-0-05.webp", "description": "Super-potent Class I topical corticosteroid emulsion delivering concentrated anti-inflammatory, antipruritic, and vasoconstrictive activity for resistant steroid-responsive dermatoses. Active: Clobetasol Propionate IP / BP 0.05% w/w (0.05% w/w). Indication: Plaque psoriasis, recalcitrant eczema, lichen planus, and discoid lupus erythematosus.", "sku": "AKP-022", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Clobetasol Propionate IP / BP 0.05% w/w", "strength": "0.05% w/w" } }, { "@type": "ListItem", "position": 32, "item": { "@type": [ "Product", "Drug" ], "name": "Methylcobalamin 1000mcg, Pyridoxine HCl 100mg, Niacinamide 100mg & D-Panthenol 50mg Injection (per 2ml)", "url": "https://www.akumaenterprises-pharma.com/product/methylcobalamin-1000mcg-pyridoxine-hcl-100mg-niacinamide-100-akp-055", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-055-methylcobalamin-1000mcg-pyridoxine-hcl-1.webp", "description": "Neuro-regenerative active-coenzyme B12 + B-complex parenteral injection delivering high-dose myelin synthesis support and rapid restoration of peripheral nerve conduction. Active: Methylcobalamin JP 1000 mcg + Pyridoxine HCl IP 100 mg + Niacinamide IP 100 mg + D-Panthenol 50 mg (1000 mcg + 100 mg + 100 mg + 50 mg / 2 ml). Indication: Diabetic peripheral neuropathy, megaloblastic anemia, sciatica, trigeminal neuralgia, and severe B-vitamin depletion.", "sku": "AKP-055", "category": "Liquid Injections \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Ampoule", "activeIngredient": "Methylcobalamin JP 1000 mcg + Pyridoxine HCl IP 100 mg + Niacinamide IP 100 mg + D-Panthenol 50 mg", "strength": "1000 mcg + 100 mg + 100 mg + 50 mg / 2 ml" } }, { "@type": "ListItem", "position": 33, "item": { "@type": [ "Product", "Drug" ], "name": "Ofloxacin 0.3% w/v Eye/Ear Drops", "url": "https://www.akumaenterprises-pharma.com/product/ofloxacin-0-3-w-v-eye-ear-drops-akp-063", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-063-ofloxacin-0-3-w-v-eye-ear-drops.webp", "description": "Dual-utility sterile fluoroquinolone ophthalmic and otic solution buffered to physiological tear/ear pH for broad coverage against Staphylococcus, Streptococcus, and Pseudomonas. Active: Ofloxacin IP 0.3% w/v (0.3% w/v). Indication: Bacterial conjunctivitis, keratitis, acute otitis externa, and chronic suppurative otitis media.", "sku": "AKP-063", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Ophthalmic / Otic Drops", "activeIngredient": "Ofloxacin IP 0.3% w/v", "strength": "0.3% w/v" } }, { "@type": "ListItem", "position": 34, "item": { "@type": [ "Product", "Drug" ], "name": "Crocin Baby Drops (Paracetamol Paediatric Oral Drops IP 100mg/ml)", "url": "https://www.akumaenterprises-pharma.com/product/crocin-baby-drops-paracetamol-paediatric-oral-drops-ip-100mg-akp-095", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-095-crocin-baby-drops-paracetamol-paediatric.webp", "description": "Trusted paediatric antipyretic and analgesic oral drops calibrated for safe infant fever management, post-immunization discomfort, and mild teething pain with a precision graduated dropper. Active: Paracetamol IP (Acetaminophen) (100mg / ml). Indication: Infant pyrexia, fever, post-immunization pyrexia, analgesic.", "sku": "AKP-095", "category": "Drops \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Drops (Paediatric)", "activeIngredient": "Paracetamol IP (Acetaminophen)", "strength": "100mg / ml" } }, { "@type": "ListItem", "position": 35, "item": { "@type": [ "Product", "Drug" ], "name": "Cefpodoxime Proxetil 50mg Dry Syrup (per 5ml Reconstituted Suspension)", "url": "https://www.akumaenterprises-pharma.com/product/cefpodoxime-proxetil-50mg-dry-syrup-per-5ml-reconstituted-su-akp-083", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-083-cefpodoxime-proxetil-50mg-dry-syrup-per.webp", "description": "Taste-masked prodrug cephalosporin dry granules delivering potent bactericidal beta-lactamase stability against common pediatric respiratory and ENT pathogens. Active: Cefpodoxime Proxetil IP (eq. Cefpodoxime 50 mg / 5 ml) (50 mg / 5 ml). Indication: Paediatric community-acquired pneumonia, acute otitis media, bacterial sinusitis, and skin infections.", "sku": "AKP-083", "category": "Dry Syrup \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Dry Syrup (Oral Suspension)", "activeIngredient": "Cefpodoxime Proxetil IP (eq. Cefpodoxime 50 mg / 5 ml)", "strength": "50 mg / 5 ml" } }, { "@type": "ListItem", "position": 36, "item": { "@type": [ "Product", "Drug" ], "name": "Ethanol IP 70% v/v Gel Base Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/ethanol-ip-70-v-v-gel-base-sanitizer-akp-089", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-089-ethanol-ip-70-v-v-gel-base-sanitizer.webp", "description": "Pharmacopoeial ethanol 70% v/v hygienic gel hand sanitizer delivering broad antimicrobial and virucidal contact kill alongside dermatologically mild moisturizers. Active: Ethanol IP 70% v/v + Soothing Emollient Gel Base (70% v/v Ethanol). Indication: Broad-spectrum healthcare and commercial hand sanitization against enveloped viruses and bacteria.", "sku": "AKP-089", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Antiseptic Hand Sanitizer Gel", "activeIngredient": "Ethanol IP 70% v/v + Soothing Emollient Gel Base", "strength": "70% v/v Ethanol" } }, { "@type": "ListItem", "position": 37, "item": { "@type": [ "Product", "Drug" ], "name": "Pantoprazole (eq. 20mg) & Domperidone 10mg Tablets (Enteric Coated)", "url": "https://www.akumaenterprises-pharma.com/product/pantoprazole-eq-20mg-domperidone-10mg-tablets-enteric-coated-akp-006", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-006-pantoprazole-eq-20mg-domperidone-10mg-ta.webp", "description": "Balanced gastro-prokinetic enteric-coated tablet shielding acid-labile pantoprazole through gastric transit while domperidone accelerates gastric emptying to curb reflux, nausea, and early satiety. Active: Pantoprazole Sodium (eq. Pantoprazole 20 mg) + Domperidone IP 10 mg (20 mg + 10 mg). Indication: Mild-to-moderate gastroesophageal reflux disease (GERD), functional dyspepsia, and NSAID-associated gastritis.", "sku": "AKP-006", "category": "Tablets \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Tablets", "activeIngredient": "Pantoprazole Sodium (eq. Pantoprazole 20 mg) + Domperidone IP 10 mg", "strength": "20 mg + 10 mg" } }, { "@type": "ListItem", "position": 38, "item": { "@type": "Product", "name": "AOD9604 Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/aod9604-acetate-research-peptide-akp-rp-02", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-02-aod9604-acetate.webp", "description": "C-terminal hGH (176-191) fragment peptide studied in vitro for lipolytic pathway signaling without IGF-1 cross-reactivity. Research area: Metabolic health. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 221231-10-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: AOD9604 Acetate (CAS 221231-10-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Metabolic health.", "sku": "AKP-RP-02", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "221231-10-3" } }, { "@type": "ListItem", "position": 39, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 60 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-60-mg-akp-005-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-005-artesunate-60mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (60 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 60 mg (60 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-005-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 60 mg", "strength": "60 mg" } }, { "@type": "ListItem", "position": 40, "item": { "@type": [ "Product", "Drug" ], "name": "Chloroquine Phosphate Oral Suspension 160 mg / 10 ml", "url": "https://www.akumaenterprises-pharma.com/product/chloroquine-phosphate-oral-suspension-160-mg-10-ml-akp-031-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-031-chloroquine-phosphate-160mg-10ml-suspension.webp", "description": "Taste-masked paediatric chloroquine phosphate liquid suspension (160 mg / 10 ml) facilitating accurate weight-calibrated antimalarial administration in infants and young children. Active: Chloroquine Phosphate 160 mg / 10 ml (160 mg / 10 ml). Indication: Paediatric susceptible malaria fever clearance and pediatric hepatic amoebiasis.", "sku": "AKP-031-MAL", "category": "Oral Liquids \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Oral Suspension", "activeIngredient": "Chloroquine Phosphate 160 mg / 10 ml", "strength": "160 mg / 10 ml" } }, { "@type": "ListItem", "position": 41, "item": { "@type": [ "Product", "Drug" ], "name": "Silodosin Capsules 2 mg", "url": "https://www.akumaenterprises-pharma.com/product/silodosin-capsules-2-mg-akp-076-sw", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-076-silodosin-2mg-capsules.webp", "description": "Precision-filled hard gelatin capsule containing uroselective alpha-1A adrenoceptor antagonist silodosin (2 mg) tailored for renal-adjusted (2 mg), standard (4 mg), or high-efficacy (8 mg) BPH regimens. Active: Silodosin 2 mg (2 mg). Indication: Dose-titrated symptomatic management of benign prostatic hyperplasia (BPH) and bladder outlet obstruction.", "sku": "AKP-076-SW", "category": "Capsules \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Silodosin 2 mg", "strength": "2 mg" } }, { "@type": "ListItem", "position": 42, "item": { "@type": [ "Product", "Drug" ], "name": "Fluticasone Propionate 0.05% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/fluticasone-propionate-0-05-w-v-nasal-spray-akp-072", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-072-fluticasone-propionate-0-05-w-v-nasal-sp.webp", "description": "Proven aqueous microsuspension intranasal glucocorticoid spray delivering precise 50 mcg metered doses to downregulate eosinophil-driven allergic mucosal edema. Active: Fluticasone Propionate BP / IP 0.05% w/v (0.05% w/v (50 mcg/spray)). Indication: Allergic rhinitis, non-allergic vasomotor rhinitis, and nasal polyp prophylaxis.", "sku": "AKP-072", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Metered-Dose Nasal Spray", "activeIngredient": "Fluticasone Propionate BP / IP 0.05% w/v", "strength": "0.05% w/v (50 mcg/spray)" } }, { "@type": "ListItem", "position": 43, "item": { "@type": [ "Product", "Drug" ], "name": "Miconazole Cream 2.0%", "url": "https://www.akumaenterprises-pharma.com/product/miconazole-cream-2-0-akp-023", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-023-miconazole-cream-2-0.webp", "description": "Broad-spectrum imidazole antifungal topical cream disrupting fungal ergosterol biosynthesis and providing soothing dermal barrier recovery in yeast and dermatophyte skin infections. Active: Miconazole Nitrate IP / BP 2.0% w/w (2.0% w/w). Indication: Cutaneous candidiasis, pityriasis versicolor, ringworm, and superficial fungal intertrigo.", "sku": "AKP-023", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Miconazole Nitrate IP / BP 2.0% w/w", "strength": "2.0% w/w" } }, { "@type": "ListItem", "position": 44, "item": { "@type": [ "Product", "Drug" ], "name": "Nandrolone Decanoate 25mg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/nandrolone-decanoate-25mg-injection-per-ml-akp-056", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-056-nandrolone-decanoate-25mg-injection-per.webp", "description": "Long-acting anabolic depot steroid IM injection formulated to promote positive nitrogen balance, bone calcium accretion, and erythropoietin stimulation in osteoporosis and chronic wasting. Active: Nandrolone Decanoate IP / BP 25 mg (in Sterile Arachis Oil Base) (25 mg / 1 ml). Indication: Post-menopausal osteoporosis, refractory chronic kidney disease anemia, and catabolic debilitating states.", "sku": "AKP-056", "category": "Liquid Injections \u2014 Endocrine & Supportive Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Oily Depot Injection Ampoule", "activeIngredient": "Nandrolone Decanoate IP / BP 25 mg (in Sterile Arachis Oil Base)", "strength": "25 mg / 1 ml" } }, { "@type": "ListItem", "position": 45, "item": { "@type": [ "Product", "Drug" ], "name": "Ciprofloxacin HCl 0.3% w/v Eye/Ear Drops", "url": "https://www.akumaenterprises-pharma.com/product/ciprofloxacin-hcl-0-3-w-v-eye-ear-drops-akp-064", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-064-ciprofloxacin-hcl-0-3-w-v-eye-ear-drops.webp", "description": "Essential-medicines-grade fluoroquinolone ophthalmic/otic solution providing high tissue concentration against resistant ocular surface and external auditory canal infections. Active: Ciprofloxacin Hydrochloride IP (eq. Ciprofloxacin 0.3% w/v) (0.3% w/v). Indication: Corneal ulcers, purulent bacterial conjunctivitis, and Pseudomonas otitis externa (swimmer's ear).", "sku": "AKP-064", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Ophthalmic / Otic Drops", "activeIngredient": "Ciprofloxacin Hydrochloride IP (eq. Ciprofloxacin 0.3% w/v)", "strength": "0.3% w/v" } }, { "@type": "ListItem", "position": 46, "item": { "@type": [ "Product", "Drug" ], "name": "Cefpodoxime Proxetil 100mg Dry Syrup (per 5ml Reconstituted Suspension)", "url": "https://www.akumaenterprises-pharma.com/product/cefpodoxime-proxetil-100mg-dry-syrup-per-5ml-reconstituted-s-akp-084", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-084-cefpodoxime-proxetil-100mg-dry-syrup-per.webp", "description": "Concentrated 100 mg/5 ml oral cephalosporin dry syrup formulated to maximize therapeutic convenience and pediatric palatability during 10-day antibiotic courses. Active: Cefpodoxime Proxetil IP (eq. Cefpodoxime 100 mg / 5 ml) (100 mg / 5 ml). Indication: Severe paediatric respiratory tract infections, streptococcal pharyngotonsillitis, and complicated UTI.", "sku": "AKP-084", "category": "Dry Syrup \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Double-Strength Dry Syrup", "activeIngredient": "Cefpodoxime Proxetil IP (eq. Cefpodoxime 100 mg / 5 ml)", "strength": "100 mg / 5 ml" } }, { "@type": "ListItem", "position": 47, "item": { "@type": [ "Product", "Drug" ], "name": "Ethanol IP 70% v/v Rub Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/ethanol-ip-70-v-v-rub-sanitizer-akp-090", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-090-ethanol-ip-70-v-v-rub-sanitizer.webp", "description": "Hospital liquid ethanol hand rub designed for wall-mounted touchless dispensers to maintain high-compliance healthcare infection prevention protocols. Active: Ethanol IP 70% v/v (70% v/v Ethanol). Indication: Hygienic hand antisepsis across hospital clinics, outpatient departments, and diagnostic laboratories.", "sku": "AKP-090", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Antiseptic Liquid Hand Rub", "activeIngredient": "Ethanol IP 70% v/v", "strength": "70% v/v Ethanol" } }, { "@type": "ListItem", "position": 48, "item": { "@type": [ "Product", "Drug" ], "name": "Dapoxetine 30 mg & Sildenafil 50 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/dapoxetine-30-mg-sildenafil-50-mg-tablets-akp-103", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-103-dapoxetine-30mg-sildenafil-50mg-tablets.webp", "description": "Dual-mechanism male sexual wellness tablet combining selective PDE5 vasodilator Dapoxetine 30 mg & Sildenafil 50 mg with rapid-acting SSRI dapoxetine 30 mg to enhance erectile rigidity and ejaculatory latency. Active: Dapoxetine 30 mg + Sildenafil 50 mg (30 mg + 50 mg). Indication: Simultaneous treatment of erectile dysfunction (ED) and premature ejaculation (PE) in adult men.", "sku": "AKP-103", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Dapoxetine 30 mg + Sildenafil 50 mg", "strength": "30 mg + 50 mg" } }, { "@type": "ListItem", "position": 49, "item": { "@type": [ "Product", "Drug" ], "name": "Liraglutide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/liraglutide-peptide-api-akp-api-03", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-03-liraglutide.webp", "description": "Acylated GLP-1 analogue peptide API engineered for once-daily type 2 diabetes and obesity sterile injectable drug products. Indicated for T2DM, Obesity. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 204656-20-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Liraglutide (CAS 204656-20-2) (Purity \u2265 99.0% (HPLC)). Indication: T2DM, Obesity.", "sku": "AKP-API-03", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Liraglutide (CAS 204656-20-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "204656-20-2" } }, { "@type": "ListItem", "position": 50, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 250mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-250mg-injection-akp-043", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-043-ceftriaxone-sodium-250mg-injection.webp", "description": "Sterile lyophilized parenteral cephalosporin in a 250 mg strength vial tailored for paediatric dosing and targeted single-dose intramuscular or intravenous regimens. Active: Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 250 mg) (250 mg). Indication: Paediatric lower respiratory infections, uncomplicated gonococcal infection, otitis media, and surgical prophylaxis.", "sku": "AKP-043", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 250 mg)", "strength": "250 mg" } }, { "@type": "ListItem", "position": 51, "item": { "@type": [ "Product", "Drug" ], "name": "Sucralfate 1gm Suspension (per 10ml)", "url": "https://www.akumaenterprises-pharma.com/product/sucralfate-1gm-suspension-per-10ml-akp-034", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-034-sucralfate-1gm-suspension-per-10ml.webp", "description": "Mucosal protective aluminium sucrose sulfate suspension forming a viscous, acid-resistant barrier over ulcer craters to accelerate epithelial healing without systemic absorption. Active: Sucralfate USP / IP 1000 mg (per 10 ml) (1 g / 10 ml). Indication: Active duodenal ulcer, gastric ulcer, gastroesophageal mucosal erosion, and stress ulcer prophylaxis.", "sku": "AKP-034", "category": "Oral Liquids \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Cytoprotective Suspension", "activeIngredient": "Sucralfate USP / IP 1000 mg (per 10 ml)", "strength": "1 g / 10 ml" } }, { "@type": "ListItem", "position": 52, "item": { "@type": [ "Product", "Drug" ], "name": "Oseltamivir Capsules IP 45 mg", "url": "https://www.akumaenterprises-pharma.com/product/oseltamivir-capsules-ip-45-mg-akp-049-av", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-049-oseltamivir-45mg-capsules.webp", "description": "Potent oral neuraminidase inhibitor antiviral capsule (45 mg oseltamivir phosphate) arresting influenza A & B virion shedding and accelerating recovery when initiated within 48 hours of symptom onset. Active: Oseltamivir IP 45 mg (45 mg). Indication: Treatment and post-exposure prophylaxis of acute Influenza A and B viral infections (listed under Antiretrovirals / Antivirals sector per master product schedule).", "sku": "AKP-049-AV", "category": "Capsules \u2014 Antiretrovirals / Antivirals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Oseltamivir IP 45 mg", "strength": "45 mg" } }, { "@type": "ListItem", "position": 53, "item": { "@type": [ "Product", "Drug" ], "name": "Sodium Chloride 0.65% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/sodium-chloride-0-65-w-v-nasal-spray-akp-075", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-075-sodium-chloride-0-65-w-v-nasal-spray.webp", "description": "Gentle drug-free isotonic buffered saline mist restoring physiological mucociliary clearance and hydrating dry inflamed nasal mucosa without rebound congestion. Active: Sodium Chloride IP 0.65% w/v (Isotonic Buffered Saline) (0.65% w/v). Indication: Infant and adult dry nasal passages, crusted mucus clearance, post-sinus surgery irrigation, and coryza.", "sku": "AKP-075", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Isotonic Saline Nasal Spray / Drops", "activeIngredient": "Sodium Chloride IP 0.65% w/v (Isotonic Buffered Saline)", "strength": "0.65% w/v" } }, { "@type": "ListItem", "position": 54, "item": { "@type": [ "Product", "Drug" ], "name": "Clobetasol Propionate 0.05% & Salicylic Acid 6.5% Ointment", "url": "https://www.akumaenterprises-pharma.com/product/clobetasol-propionate-0-05-salicylic-acid-6-5-ointment-akp-025", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-025-clobetasol-propionate-0-05-salicylic-aci.webp", "description": "Dual-action high-potency corticosteroid and keratolytic ointment formulated to desquamate thick hyperkeratotic plaques while enhancing dermal penetration to suppress underlying inflammation. Active: Clobetasol Propionate IP 0.05% w/w + Salicylic Acid IP 6.5% w/w (0.05% + 6.5% w/w). Indication: Hyperkeratotic plaque psoriasis, chronic lichenified eczema, and scaling palmoplantar dermatoses.", "sku": "AKP-025", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Keratolytic Topical Ointment", "activeIngredient": "Clobetasol Propionate IP 0.05% w/w + Salicylic Acid IP 6.5% w/w", "strength": "0.05% + 6.5% w/w" } }, { "@type": "ListItem", "position": 55, "item": { "@type": [ "Product", "Drug" ], "name": "Ondansetron HCl 2mg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/ondansetron-hcl-2mg-injection-per-ml-akp-058", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-058-ondansetron-hcl-2mg-injection-per-ml.webp", "description": "Selective 5-HT3 serotonin receptor antagonist parenteral antiemetic acting at both chemoreceptor trigger zone and vagal nerve terminals for rapid surgical and emergency emesis arrest. Active: Ondansetron Hydrochloride IP (eq. Ondansetron 2 mg per ml) (2 mg / 1 ml (4 mg / 2 ml pack)). Indication: Post-operative nausea and vomiting (PONV), chemotherapy-induced emesis, and acute refractory gastroenteritis vomiting.", "sku": "AKP-058", "category": "Liquid Injections \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Ampoule", "activeIngredient": "Ondansetron Hydrochloride IP (eq. Ondansetron 2 mg per ml)", "strength": "2 mg / 1 ml (4 mg / 2 ml pack)" } }, { "@type": "ListItem", "position": 56, "item": { "@type": [ "Product", "Drug" ], "name": "Carboxymethylcellulose Sodium 0.5% w/v Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/carboxymethylcellulose-sodium-0-5-w-v-eye-drops-akp-065", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-065-carboxymethylcellulose-sodium-0-5-w-v-ey.webp", "description": "Isotonic physiological artificial tears formulated with 0.5% carboxymethylcellulose and stabilized electrolyte profile for prolonged mucoadhesive tear-film stability without vision blurring. Active: Carboxymethylcellulose Sodium IP 0.5% w/v (0.5% w/v). Indication: Mild-to-moderate dry eye syndrome, digital eye strain, postoperative corneal dryness, and wind/sun irritation.", "sku": "AKP-065", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Lubricating Eye Drops", "activeIngredient": "Carboxymethylcellulose Sodium IP 0.5% w/v", "strength": "0.5% w/v" } }, { "@type": "ListItem", "position": 57, "item": { "@type": [ "Product", "Drug" ], "name": "Ethanol IP 70%, Hydrogen Peroxide 0.125% & Glycerol 1.45% v/v Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/ethanol-ip-70-hydrogen-peroxide-0-125-glycerol-1-45-v-v-sani-akp-091", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-091-ethanol-ip-70-hydrogen-peroxide-0-125-gl.webp", "description": "WHO-aligned liquid hand rub formulation uniting fast virucidal ethanol, sporicidal trace hydrogen peroxide, and barrier-preserving pharmaceutical glycerol. Active: Ethanol IP 70% v/v + Hydrogen Peroxide IP 0.125% v/v + Glycerol IP 1.45% v/v (70% + 0.125% + 1.45% v/v). Indication: WHO-recommended hygienic and pre-operative hand rub eliminating vegetative bacteria and spores.", "sku": "AKP-091", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "WHO-Formula Antiseptic Hand Rub", "activeIngredient": "Ethanol IP 70% v/v + Hydrogen Peroxide IP 0.125% v/v + Glycerol IP 1.45% v/v", "strength": "70% + 0.125% + 1.45% v/v" } }, { "@type": "ListItem", "position": 58, "item": { "@type": [ "Product", "Drug" ], "name": "Artemether 80 mg & Lumefantrine 480 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/artemether-80-mg-lumefantrine-480-mg-tablets-akp-030-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-030-artemether-80mg-lumefantrine-480mg-tablets.webp", "description": "WHO-recommended 3-day fixed-dose artemisinin-based combination therapy (ACT) pairing fast-acting artemether 80 mg parasite clearance with long-acting lumefantrine 480 mg recrudescence prevention. Active: Artemether 80 mg + Lumefantrine 480 mg (80 mg + 480 mg). Indication: First-line oral treatment of acute uncomplicated Plasmodium falciparum malaria (including multidrug-resistant strains).", "sku": "AKP-030-MAL", "category": "Tablets \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Artemether 80 mg + Lumefantrine 480 mg", "strength": "80 mg + 480 mg" } }, { "@type": "ListItem", "position": 59, "item": { "@type": "Product", "name": "BPC-157 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/bpc-157-research-peptide-akp-rp-03", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-03-bpc-157.webp", "description": "Stable gastric pentadecapeptide research reference standard used in angiogenesis, cytoprotection, and tendon-healing assay models. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 137525-51-0) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: BPC-157 (CAS 137525-51-0) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-03", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "137525-51-0" } }, { "@type": "ListItem", "position": 60, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 90 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-90-mg-akp-006-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-006-artesunate-90mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (90 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 90 mg (90 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-006-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 90 mg", "strength": "90 mg" } }, { "@type": "ListItem", "position": 61, "item": { "@type": [ "Product", "Drug" ], "name": "Chlorpheniramine Maleate 2mg, Dextromethorphan Hydrobromide 10mg & Phenylephrine HCl 5mg Syrup (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/chlorpheniramine-maleate-2mg-dextromethorphan-hydrobromide-1-akp-038", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-038-chlorpheniramine-maleate-2mg-dextrometho.webp", "description": "Non-narcotic cough suppressant, antihistamine, and nasal decongestant syrup targeting dry irritant cough reflexes alongside rhinorrhea and sinus stuffiness. Active: Chlorpheniramine Maleate IP 2 mg + Dextromethorphan HBr IP 10 mg + Phenylephrine HCl IP 5 mg (2 mg + 10 mg + 5 mg / 5 ml). Indication: Dry unproductive hacking cough, post-nasal drip, common cold nasal congestion, and allergic rhinorrhea.", "sku": "AKP-038", "category": "Oral Liquids \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Antitussive Syrup", "activeIngredient": "Chlorpheniramine Maleate IP 2 mg + Dextromethorphan HBr IP 10 mg + Phenylephrine HCl IP 5 mg", "strength": "2 mg + 10 mg + 5 mg / 5 ml" } }, { "@type": "ListItem", "position": 62, "item": { "@type": [ "Product", "Drug" ], "name": "Omeprazole 20mg & Domperidone 10mg Capsules", "url": "https://www.akumaenterprises-pharma.com/product/omeprazole-20mg-domperidone-10mg-capsules-akp-012", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-012-omeprazole-20mg-domperidone-10mg-capsule.webp", "description": "Fixed-dose PPI and peripheral prokinetic hard gelatin capsule offering dual symptomatic control of gastric hyperacidity, heartburn, and delayed gastric emptying. Active: Omeprazole IP 20 mg + Domperidone IP 10 mg (20 mg + 10 mg). Indication: Acid reflux with nausea, diabetic gastroparesis symptoms, and chronic gastritis.", "sku": "AKP-012", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Omeprazole IP 20 mg + Domperidone IP 10 mg", "strength": "20 mg + 10 mg" } }, { "@type": "ListItem", "position": 63, "item": { "@type": [ "Product", "Drug" ], "name": "Xylometazoline Hydrochloride 0.05% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/xylometazoline-hydrochloride-0-05-w-v-nasal-spray-akp-076", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-076-xylometazoline-hydrochloride-0-05-w-v-na.webp", "description": "Paediatric-strength alpha-adrenergic topical vasoconstrictor nasal solution relieving blocked pediatric nasal airways within 5 minutes for up to 10 hours. Active: Xylometazoline Hydrochloride IP 0.05% w/v (0.05% w/v). Indication: Paediatric nasal congestion due to common cold, sinusitis, and allergic rhinitis (children 2\u201312 years).", "sku": "AKP-076", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Decongestant Nasal Spray", "activeIngredient": "Xylometazoline Hydrochloride IP 0.05% w/v", "strength": "0.05% w/v" } }, { "@type": "ListItem", "position": 64, "item": { "@type": [ "Product", "Drug" ], "name": "Mometasone Cream 0.1%", "url": "https://www.akumaenterprises-pharma.com/product/mometasone-cream-0-1-akp-026", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-026-mometasone-cream-0-1.webp", "description": "Once-daily medium-to-high potency non-fluorinated corticosteroid cream with favorable local-to-systemic risk ratio for sensitive inflammatory eczema and allergic dermatitis. Active: Mometasone Furoate IP / USP 0.1% w/w (0.1% w/w). Indication: Atopic dermatitis, contact dermatitis, seborrheic dermatitis, and pruritic dermatoses.", "sku": "AKP-026", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Mometasone Furoate IP / USP 0.1% w/w", "strength": "0.1% w/w" } }, { "@type": "ListItem", "position": 65, "item": { "@type": [ "Product", "Drug" ], "name": "Artemether Injection 20 mg / ml", "url": "https://www.akumaenterprises-pharma.com/product/artemether-injection-20-mg-ml-akp-005-liq", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-005-liq-artemether-20mg-injection.webp", "description": "Ready-to-inject lipid-soluble artemisinin derivative (20 mg / ml) in USP Type I glass ampoules delivering rapid intra-erythrocytic schizonticidal action for ICU and rural malaria clinics. Active: Artemether 20 mg / ml (20 mg / ml). Indication: Severe chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria emergency care.", "sku": "AKP-005-LIQ", "category": "Liquid Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Intramuscular Liquid Injection Ampoule", "activeIngredient": "Artemether 20 mg / ml", "strength": "20 mg / ml" } }, { "@type": "ListItem", "position": 66, "item": { "@type": [ "Product", "Drug" ], "name": "Moxifloxacin 0.5% & Ketorolac Tromethamine 0.5% Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/moxifloxacin-0-5-ketorolac-tromethamine-0-5-eye-drops-akp-066", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-066-moxifloxacin-0-5-ketorolac-tromethamine.webp", "description": "Steroid-free antibiotic and ocular NSAID eye drop controlling post-surgical ocular pain and prostaglandin inflammation without elevating intraocular pressure. Active: Moxifloxacin Hydrochloride 0.5% w/v + Ketorolac Tromethamine IP 0.5% w/v (0.5% + 0.5% w/v). Indication: Post-cataract ocular inflammation/pain prophylaxis, seasonal allergic conjunctivitis with secondary bacterial infection.", "sku": "AKP-066", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Ophthalmic Combination Drops", "activeIngredient": "Moxifloxacin Hydrochloride 0.5% w/v + Ketorolac Tromethamine IP 0.5% w/v", "strength": "0.5% + 0.5% w/v" } }, { "@type": "ListItem", "position": 67, "item": { "@type": [ "Product", "Drug" ], "name": "Chlorhexidine Gluconate 1% & Isopropyl Alcohol 61% w/v Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/chlorhexidine-gluconate-1-isopropyl-alcohol-61-w-v-sanitizer-akp-092", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-092-chlorhexidine-gluconate-1-isopropyl-alco.webp", "description": "Waterless surgical hand scrub pairing immediate alcohol microbial kill with persistent residual antimicrobial binding of chlorhexidine gluconate under surgical gloves for hours. Active: Chlorhexidine Gluconate 1.0% w/v + Isopropyl Alcohol 61.0% w/v (1.0% + 61% w/v). Indication: Pre-operative surgical hand preparation and high-risk ICU invasive-procedure hand antisepsis.", "sku": "AKP-092", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Surgical Antiseptic Hand Scrub", "activeIngredient": "Chlorhexidine Gluconate 1.0% w/v + Isopropyl Alcohol 61.0% w/v", "strength": "1.0% + 61% w/v" } }, { "@type": "ListItem", "position": 68, "item": { "@type": [ "Product", "Drug" ], "name": "Dapagliflozin 10 mg & Metformin HCl 1000 mg ER Tablets", "url": "https://www.akumaenterprises-pharma.com/product/dapagliflozin-10-mg-metformin-hcl-1000-mg-er-tablets-akp-100-dm", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-100-dapagliflozin-10mg-metformin-1000mg-er-tablets.webp", "description": "Once-daily insulin-independent SGLT2 inhibitor dapagliflozin 10 mg combined with extended-release metformin HCl (1000 mg) promoting urinary glucose excretion alongside hepatic gluconeogenesis suppression. Active: Dapagliflozin 10 mg + Metformin HCl 1000 mg (ER) (10 mg + 1000 mg (ER)). Indication: Type 2 diabetes mellitus glycemic control, cardiovascular-renal risk reduction, and weight-favorable glucose lowering.", "sku": "AKP-100-DM", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Extended-Release Bilayer Tablets", "activeIngredient": "Dapagliflozin 10 mg + Metformin HCl 1000 mg (ER)", "strength": "10 mg + 1000 mg (ER)" } }, { "@type": "ListItem", "position": 69, "item": { "@type": [ "Product", "Drug" ], "name": "Tirzepatide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/tirzepatide-peptide-api-akp-api-04", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-04-tirzepatide.webp", "description": "Dual GIP and GLP-1 receptor co-agonist peptide API supporting metabolic, glycemic, and weight-management pharmaceutical programs. Indicated for T2DM, Weight management. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 2023788-19-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Tirzepatide (CAS 2023788-19-2) (Purity \u2265 99.0% (HPLC)). Indication: T2DM, Weight management.", "sku": "AKP-API-04", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Tirzepatide (CAS 2023788-19-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "2023788-19-2" } }, { "@type": "ListItem", "position": 70, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 1000mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-1000mg-injection-akp-044", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-044-ceftriaxone-sodium-1000mg-injection.webp", "description": "Flagship once-daily 1 g parenteral third-generation cephalosporin powder vial delivering high CNS, biliary, and pulmonary tissue concentrations across severe hospital bacterial infections. Active: Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 1000 mg) (1000 mg (1 g)). Indication: Bacterial meningitis, enteric typhoid fever, community-acquired pneumonia, septicemia, and complicated UTI.", "sku": "AKP-044", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 1000 mg)", "strength": "1000 mg (1 g)" } }, { "@type": "ListItem", "position": 71, "item": { "@type": [ "Product", "Drug" ], "name": "Ferric Ammonium Citrate 160mg, Folic Acid 1mg, Vitamin B12 5mcg & Zinc Sulphate 30mcg Syrup (per 15ml)", "url": "https://www.akumaenterprises-pharma.com/product/ferric-ammonium-citrate-160mg-folic-acid-1mg-vitamin-b12-5mc-akp-040", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-040-ferric-ammonium-citrate-160mg-folic-acid.webp", "description": "Well-tolerated non-constipating elemental iron and hematopoietic B-vitamin oral syrup formulated with folic acid and zinc to restore hemoglobin synthesis without metallic gastric irritation. Active: Ferric Ammonium Citrate 160 mg + Folic Acid IP 1 mg + Cyanocobalamin (Vit B12) IP 5 mcg + Zinc Sulphate 30 mcg (160 mg + 1 mg + 5 mcg + 30 mcg / 15 ml). Indication: Iron-deficiency anemia, nutritional megaloblastic anemia, pregnancy supplementation, and post-surgical blood loss recovery.", "sku": "AKP-040", "category": "Oral Liquids \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Haematinic Tonic Syrup", "activeIngredient": "Ferric Ammonium Citrate 160 mg + Folic Acid IP 1 mg + Cyanocobalamin (Vit B12) IP 5 mcg + Zinc Sulphate 30 mcg", "strength": "160 mg + 1 mg + 5 mcg + 30 mcg / 15 ml" } }, { "@type": "ListItem", "position": 72, "item": { "@type": [ "Product", "Drug" ], "name": "Itraconazole 200mg Capsules (Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/itraconazole-200mg-capsules-pellets-akp-018", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-018-itraconazole-200mg-capsules-pellets.webp", "description": "High-strength 200 mg multi-particulate triazole antifungal capsule formulated for convenient once-daily systemic eradication of recalcitrant cutaneous and deep fungal pathogens. Active: Itraconazole BP / IP 200 mg (Pelletized) (200 mg). Indication: Pulse therapy for fungal nail infections, invasive aspergillosis, blastomycosis, and recurrent dermatophytosis.", "sku": "AKP-018", "category": "Capsules \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Supra-Bioavailable Pellet Capsules", "activeIngredient": "Itraconazole BP / IP 200 mg (Pelletized)", "strength": "200 mg" } }, { "@type": "ListItem", "position": 73, "item": { "@type": [ "Product", "Drug" ], "name": "Xylometazoline Hydrochloride 0.1% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/xylometazoline-hydrochloride-0-1-w-v-nasal-spray-akp-077", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-077-xylometazoline-hydrochloride-0-1-w-v-nas.webp", "description": "Adult-strength rapid intranasal decongestant spray shrinking engorged nasal turbinate arterioles to facilitate sinus drainage and restorative sleep. Active: Xylometazoline Hydrochloride IP 0.1% w/v (0.1% w/v). Indication: Acute nasal congestion in adults caused by viral coryza, acute sinusitis, and allergic rhinitis.", "sku": "AKP-077", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Adult Decongestant Nasal Spray", "activeIngredient": "Xylometazoline Hydrochloride IP 0.1% w/v", "strength": "0.1% w/v" } }, { "@type": "ListItem", "position": 74, "item": { "@type": [ "Product", "Drug" ], "name": "Clindamycin 1.0% & Nicotinamide 4.0% Gel", "url": "https://www.akumaenterprises-pharma.com/product/clindamycin-1-0-nicotinamide-4-0-gel-akp-027", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-027-clindamycin-1-0-nicotinamide-4-0-gel.webp", "description": "Oil-free aqueous anti-acne gel pairing lincosamide bacteriostatic inhibition of Cutibacterium acnes with anti-inflammatory vitamin B3 (nicotinamide) sebum regulation. Active: Clindamycin Phosphate USP (eq. 1.0% w/w) + Nicotinamide IP 4.0% w/w (1.0% + 4.0% w/w). Indication: Mild-to-moderate inflammatory acne vulgaris (papules and pustules).", "sku": "AKP-027", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Anti-Acne Gel", "activeIngredient": "Clindamycin Phosphate USP (eq. 1.0% w/w) + Nicotinamide IP 4.0% w/w", "strength": "1.0% + 4.0% w/w" } }, { "@type": "ListItem", "position": 75, "item": { "@type": [ "Product", "Drug" ], "name": "Amikacin Sulphate 250mg Injection (per 2ml)", "url": "https://www.akumaenterprises-pharma.com/product/amikacin-sulphate-250mg-injection-per-2ml-akp-052", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-052-amikacin-sulphate-250mg-injection-per-2m.webp", "description": "Intermediate-strength 250 mg/2 ml aminoglycoside parenteral solution offering stability against aminoglycoside-inactivating enzymes in systemic bacterial sepsis. Active: Amikacin Sulphate IP (eq. Amikacin 250 mg per 2 ml) (250 mg / 2 ml). Indication: Hospital-acquired gram-negative pneumonia, peritonitis, complicated UTI, and bone infections.", "sku": "AKP-052", "category": "Liquid Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Vial / Ampoule", "activeIngredient": "Amikacin Sulphate IP (eq. Amikacin 250 mg per 2 ml)", "strength": "250 mg / 2 ml" } }, { "@type": "ListItem", "position": 76, "item": { "@type": [ "Product", "Drug" ], "name": "Neomycin Sulphate 0.5%, Beclomethasone Dipropionate 0.025%, Clotrimazole 1.0% & Lignocaine HCl 2.0% Ear Drops", "url": "https://www.akumaenterprises-pharma.com/product/neomycin-sulphate-0-5-beclomethasone-dipropionate-0-025-clot-akp-067", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-067-neomycin-sulphate-0-5-beclomethasone-dip.webp", "description": "Comprehensive four-in-one antibacterial, antifungal, anti-inflammatory corticosteroid, and local anaesthetic ear drop targeting mixed otomycosis and painful swimmer's ear. Active: Neomycin Sulphate 0.5% + Beclomethasone Dipropionate 0.025% + Clotrimazole 1.0% + Lignocaine HCl 2.0% (0.5% + 0.025% + 1.0% + 2.0% w/v). Indication: Mixed bacterial and fungal otitis externa (otomycosis), ear canal pruritus, edema, and otalgia.", "sku": "AKP-067", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Multi-Action Ear Drops", "activeIngredient": "Neomycin Sulphate 0.5% + Beclomethasone Dipropionate 0.025% + Clotrimazole 1.0% + Lignocaine HCl 2.0%", "strength": "0.5% + 0.025% + 1.0% + 2.0% w/v" } }, { "@type": "ListItem", "position": 77, "item": { "@type": [ "Product", "Drug" ], "name": "Chlorhexidine Gluconate Solution (eq. Chlorhexidine 0.5%) & Isopropyl Alcohol 70% v/v Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/chlorhexidine-gluconate-solution-eq-chlorhexidine-0-5-isopro-akp-093", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-093-chlorhexidine-gluconate-solution-eq-chlo.webp", "description": "Dual-agent persistent hospital hand and skin disinfectant combining 70% IPA instant bactericidal action with 0.5% chlorhexidine residual cumulative protection. Active: Chlorhexidine Gluconate Solution (eq. 0.5% w/v) + Isopropyl Alcohol 70% v/v (0.5% CHG + 70% IPA v/v). Indication: Routine ICU hand antisepsis, catheter insertion site skin prep, and multi-drug resistant organism control.", "sku": "AKP-093", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hospital Disinfectant Hand Rub", "activeIngredient": "Chlorhexidine Gluconate Solution (eq. 0.5% w/v) + Isopropyl Alcohol 70% v/v", "strength": "0.5% CHG + 70% IPA v/v" } }, { "@type": "ListItem", "position": 78, "item": { "@type": [ "Product", "Drug" ], "name": "Ofloxacin 200mg & Ornidazole 500mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/ofloxacin-200mg-ornidazole-500mg-tablets-akp-002", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-002-ofloxacin-200mg-ornidazole-500mg-tablets.webp", "description": "Dual-action antimicrobial fixed-dose combination pairing fluoroquinolone bactericidal coverage with nitroimidazole anaerobic and antiprotozoal activity for mixed gastrointestinal and gynecological infections. Active: Ofloxacin IP + Ornidazole IP (200 mg + 500 mg). Indication: Mixed aerobic and anaerobic GI infections, infectious diarrhea, dysentery, and pelvic inflammatory disease.", "sku": "AKP-002", "category": "Tablets \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Ofloxacin IP + Ornidazole IP", "strength": "200 mg + 500 mg" } }, { "@type": "ListItem", "position": 79, "item": { "@type": "Product", "name": "BPC-157 (Arginate) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/bpc-157-arginate-research-peptide-akp-rp-04", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-04-bpc-157-arginate.webp", "description": "Arginate salt form of gastric pentadecapeptide BPC-157 offering enhanced thermal and acidic stability in laboratory research. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, Ref Arginate Salt) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: BPC-157 (Arginate) (Ref Arginate Salt) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-04", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." } } }, { "@type": "ListItem", "position": 80, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 120 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-120-mg-akp-007-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-007-artesunate-120mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (120 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 120 mg (120 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-007-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 120 mg", "strength": "120 mg" } }, { "@type": "ListItem", "position": 81, "item": { "@type": [ "Product", "Drug" ], "name": "Aluminium Hydroxide 200mg, Magnesium Hydroxide 200mg & Simethicone 25mg Suspension (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/aluminium-hydroxide-200mg-magnesium-hydroxide-200mg-simethic-akp-035", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-035-aluminium-hydroxide-200mg-magnesium-hydr.webp", "description": "Classic balanced antacid-antiflatulent liquid combining fast-acting magnesium hydroxide with sustained aluminium hydroxide buffering and bowel-motility equilibrium. Active: Aluminium Hydroxide Gel IP 200 mg + Magnesium Hydroxide IP 200 mg + Simethicone IP 25 mg (200 mg + 200 mg + 25 mg / 5 ml). Indication: Hyperacidity, acid dyspepsia, heartburn, bloating, and sour eructation.", "sku": "AKP-035", "category": "Oral Liquids \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Antacid Suspension", "activeIngredient": "Aluminium Hydroxide Gel IP 200 mg + Magnesium Hydroxide IP 200 mg + Simethicone IP 25 mg", "strength": "200 mg + 200 mg + 25 mg / 5 ml" } }, { "@type": "ListItem", "position": 82, "item": { "@type": [ "Product", "Drug" ], "name": "Silodosin Capsules 4 mg", "url": "https://www.akumaenterprises-pharma.com/product/silodosin-capsules-4-mg-akp-077-sw", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-077-silodosin-4mg-capsules.webp", "description": "Precision-filled hard gelatin capsule containing uroselective alpha-1A adrenoceptor antagonist silodosin (4 mg) tailored for renal-adjusted (2 mg), standard (4 mg), or high-efficacy (8 mg) BPH regimens. Active: Silodosin 4 mg (4 mg). Indication: Dose-titrated symptomatic management of benign prostatic hyperplasia (BPH) and bladder outlet obstruction.", "sku": "AKP-077-SW", "category": "Capsules \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Silodosin 4 mg", "strength": "4 mg" } }, { "@type": "ListItem", "position": 83, "item": { "@type": [ "Product", "Drug" ], "name": "Oxymetazoline HCl 0.01% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/oxymetazoline-hcl-0-01-w-v-nasal-spray-akp-078", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-078-oxymetazoline-hcl-0-01-w-v-nasal-spray.webp", "description": "Ultra-mild 0.01% neonatal sympathomimetic nasal formulation engineered for delicate infant nasal mucosa to restore effortless breathing before feeds. Active: Oxymetazoline Hydrochloride USP / IP 0.01% w/v (0.01% w/v). Indication: Neonatal and infant nasal blockage interfering with feeding and breathing.", "sku": "AKP-078", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Neonatal / Infant Nasal Spray / Drops", "activeIngredient": "Oxymetazoline Hydrochloride USP / IP 0.01% w/v", "strength": "0.01% w/v" } }, { "@type": "ListItem", "position": 84, "item": { "@type": [ "Product", "Drug" ], "name": "Adapalene 0.1% & Clindamycin 1.0% Gel", "url": "https://www.akumaenterprises-pharma.com/product/adapalene-0-1-clindamycin-1-0-gel-akp-028", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-028-adapalene-0-1-clindamycin-1-0-gel.webp", "description": "Comedolytic third-generation retinoid and topical antibiotic combination gel normalizing follicular epithelial differentiation while suppressing acne bacterial colonization. Active: Adapalene USP 0.1% w/w + Clindamycin Phosphate (eq. 1.0% w/w) (0.1% + 1.0% w/w). Indication: Comedonal and inflammatory acne vulgaris with papulopustular lesions.", "sku": "AKP-028", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Anti-Acne Gel", "activeIngredient": "Adapalene USP 0.1% w/w + Clindamycin Phosphate (eq. 1.0% w/w)", "strength": "0.1% + 1.0% w/w" } }, { "@type": "ListItem", "position": 85, "item": { "@type": [ "Product", "Drug" ], "name": "Piroxicam 20mg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/piroxicam-20mg-injection-per-ml-akp-060", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-060-piroxicam-20mg-injection-per-ml.webp", "description": "Long-half-life oxicam NSAID intramuscular solution delivering sustained 24-hour anti-inflammatory analgesia from a single daily acute-care dose. Active: Piroxicam USP / IP 20 mg (per ml) (20 mg / 1 ml). Indication: Acute rheumatoid flare-ups, ankylosing spondylitis, acute gout, and intense postoperative musculoskeletal pain.", "sku": "AKP-060", "category": "Liquid Injections \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Ampoule", "activeIngredient": "Piroxicam USP / IP 20 mg (per ml)", "strength": "20 mg / 1 ml" } }, { "@type": "ListItem", "position": 86, "item": { "@type": [ "Product", "Drug" ], "name": "Carboxymethylcellulose Sodium 1.0% w/v Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/carboxymethylcellulose-sodium-1-0-w-v-eye-drops-akp-068", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-068-carboxymethylcellulose-sodium-1-0-w-v-ey.webp", "description": "High-viscosity 1.0% lubricating gel-drop artificial tear engineered to provide sustained corneal hydration and epithelial barrier protection in refractory keratoconjunctivitis sicca. Active: Carboxymethylcellulose Sodium IP 1.0% w/v (1.0% w/v). Indication: Severe dry eye disease, LASIK/cataract postoperative epithelial healing, and chronic nocturnal ocular dryness.", "sku": "AKP-068", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile High-Viscosity Eye Drops", "activeIngredient": "Carboxymethylcellulose Sodium IP 1.0% w/v", "strength": "1.0% w/v" } }, { "@type": "ListItem", "position": 87, "item": { "@type": [ "Product", "Drug" ], "name": "Isopropyl Alcohol IP 80% v/v Gel Base Sanitizer", "url": "https://www.akumaenterprises-pharma.com/product/isopropyl-alcohol-ip-80-v-v-gel-base-sanitizer-akp-094", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-094-isopropyl-alcohol-ip-80-v-v-gel-base-san.webp", "description": "High-potency 80% IPA gel formulation engineered for isolation units and sterile compounding anterooms requiring aggressive broad-spectrum antimicrobial hand decontamination. Active: Isopropyl Alcohol IP 80% v/v + Skin-Emollient Gel Matrix (80% v/v Isopropyl Alcohol). Indication: High-level clinical, cleanroom, and isolation-ward hand decontamination.", "sku": "AKP-094", "category": "Sanitizer \u2014 Hospital Antiseptics & Sanitization", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "High-Strength Antiseptic Sanitizer Gel", "activeIngredient": "Isopropyl Alcohol IP 80% v/v + Skin-Emollient Gel Matrix", "strength": "80% v/v Isopropyl Alcohol" } }, { "@type": "ListItem", "position": 88, "item": { "@type": [ "Product", "Drug" ], "name": "Montelukast Sodium 10mg & Levocetirizine Hydrochloride 5mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/montelukast-sodium-10mg-levocetirizine-hydrochloride-5mg-tab-akp-010", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-010-montelukast-sodium-10mg-levocetirizine-h.webp", "description": "Dual-pathway anti-allergic and anti-leukotriene film-coated tablet combining cysteinyl leukotriene receptor antagonism with H1 blockade to relieve nasal congestion, wheezing, and airway inflammation. Active: Montelukast Sodium IP 10 mg + Levocetirizine Hydrochloride IP 5 mg (10 mg + 5 mg). Indication: Persistent allergic rhinitis, chronic bronchial asthma prophylaxis, and exercise-induced bronchospasm.", "sku": "AKP-010", "category": "Tablets \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Montelukast Sodium IP 10 mg + Levocetirizine Hydrochloride IP 5 mg", "strength": "10 mg + 5 mg" } }, { "@type": "ListItem", "position": 89, "item": { "@type": [ "Product", "Drug" ], "name": "Linaclotide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/linaclotide-peptide-api-akp-api-05", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-05-linaclotide.webp", "description": "Guanylate cyclase-C (GC-C) agonist 14-amino-acid peptide API formulated for irritable bowel syndrome with constipation (IBS-C) and CIC. Indicated for IBS-C, CIC. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 851199-59-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Linaclotide (CAS 851199-59-2) (Purity \u2265 99.0% (HPLC)). Indication: IBS-C, CIC.", "sku": "AKP-API-05", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Linaclotide (CAS 851199-59-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "851199-59-2" } }, { "@type": "ListItem", "position": 90, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 250mg & Sulbactam Sodium 125mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-250mg-sulbactam-sodium-125mg-injection-akp-045", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-045-ceftriaxone-sodium-250mg-sulbactam-sodiu.webp", "description": "2:1 ratio cephalosporin and beta-lactamase inhibitor sterile vial restoring bactericidal efficacy against resistant pediatric and low-body-weight clinical isolates. Active: Ceftriaxone Sodium IP (eq. 250 mg) + Sulbactam Sodium IP (eq. 125 mg) (250 mg + 125 mg (375 mg)). Indication: Paediatric beta-lactamase producing bacterial pneumonia, skin/soft tissue infection, and UTI.", "sku": "AKP-045", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium IP (eq. 250 mg) + Sulbactam Sodium IP (eq. 125 mg)", "strength": "250 mg + 125 mg (375 mg)" } }, { "@type": "ListItem", "position": 91, "item": { "@type": [ "Product", "Drug" ], "name": "Terbutaline Sulphate 1.25mg, Ambroxol HCl 15mg, Guaiphenesin 50mg & Menthol 1.0mg Syrup (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/terbutaline-sulphate-1-25mg-ambroxol-hcl-15mg-guaiphenesin-5-akp-039", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-039-terbutaline-sulphate-1-25mg-ambroxol-hcl.webp", "description": "Potent respiratory wet-cough formulation pairing active-metabolite mucolytic ambroxol with selective beta-2 bronchodilation and surfactant stimulation to expel thick sputum. Active: Terbutaline Sulphate IP 1.25 mg + Ambroxol HCl IP 15 mg + Guaiphenesin IP 50 mg + Menthol IP 1.0 mg (1.25 mg + 15 mg + 50 mg + 1.0 mg / 5 ml). Indication: Asthmatic bronchitis, viscous mucus cough, bronchospasm, and lower respiratory tract congestion.", "sku": "AKP-039", "category": "Oral Liquids \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Bronchodilator & Mucolytic Syrup", "activeIngredient": "Terbutaline Sulphate IP 1.25 mg + Ambroxol HCl IP 15 mg + Guaiphenesin IP 50 mg + Menthol IP 1.0 mg", "strength": "1.25 mg + 15 mg + 50 mg + 1.0 mg / 5 ml" } }, { "@type": "ListItem", "position": 92, "item": { "@type": [ "Product", "Drug" ], "name": "Oseltamivir Capsules IP 75 mg", "url": "https://www.akumaenterprises-pharma.com/product/oseltamivir-capsules-ip-75-mg-akp-050-av", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-050-oseltamivir-75mg-capsules.webp", "description": "Potent oral neuraminidase inhibitor antiviral capsule (75 mg oseltamivir phosphate) arresting influenza A & B virion shedding and accelerating recovery when initiated within 48 hours of symptom onset. Active: Oseltamivir IP 75 mg (75 mg). Indication: Treatment and post-exposure prophylaxis of acute Influenza A and B viral infections (listed under Antiretrovirals / Antivirals sector per master product schedule).", "sku": "AKP-050-AV", "category": "Capsules \u2014 Antiretrovirals / Antivirals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Oseltamivir IP 75 mg", "strength": "75 mg" } }, { "@type": "ListItem", "position": 93, "item": { "@type": [ "Product", "Drug" ], "name": "Oxymetazoline HCl 0.025% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/oxymetazoline-hcl-0-025-w-v-nasal-spray-akp-079", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-079-oxymetazoline-hcl-0-025-w-v-nasal-spray.webp", "description": "Long-acting 12-hour paediatric decongestant nasal solution offering gentle sustained mucosal shrinkage with minimal reactive hyperemia. Active: Oxymetazoline Hydrochloride IP 0.025% w/v (0.025% w/v). Indication: Childhood nasal congestion in upper respiratory viral infections and sinusitis.", "sku": "AKP-079", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Paediatric Nasal Decongestant Spray", "activeIngredient": "Oxymetazoline Hydrochloride IP 0.025% w/v", "strength": "0.025% w/v" } }, { "@type": "ListItem", "position": 94, "item": { "@type": [ "Product", "Drug" ], "name": "Betamethasone 0.05% Cream", "url": "https://www.akumaenterprises-pharma.com/product/betamethasone-0-05-cream-akp-029", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-029-betamethasone-0-05-cream.webp", "description": "High-strength fluorinated corticosteroid cream engineered for smooth spreadability and rapid relief of erythema, scaling, and pruritus in acute and chronic eczema. Active: Betamethasone Dipropionate IP / BP 0.05% w/w (0.05% w/w). Indication: Cortico-responsive inflammatory and pruritic dermatoses, psoriasis, and allergic eczema.", "sku": "AKP-029", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Betamethasone Dipropionate IP / BP 0.05% w/w", "strength": "0.05% w/w" } }, { "@type": "ListItem", "position": 95, "item": { "@type": [ "Product", "Drug" ], "name": "Mecobalamin 500mcg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/mecobalamin-500mcg-injection-per-ml-akp-059", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-059-mecobalamin-500mcg-injection-per-ml.webp", "description": "Monocomponent coenzyme vitamin B12 injectable directly crossing the blood-brain barrier without hepatic conversion to repair axonal degeneration and hematopoiesis. Active: Methylcobalamin JP 500 mcg (per ml) (500 mcg / 1 ml). Indication: Vitamin B12 deficiency neuropathy, paresthesia, subacute combined degeneration, and pernicious anemia.", "sku": "AKP-059", "category": "Liquid Injections \u2014 Nutrition & Metabolic Tonics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Ampoule", "activeIngredient": "Methylcobalamin JP 500 mcg (per ml)", "strength": "500 mcg / 1 ml" } }, { "@type": "ListItem", "position": 96, "item": { "@type": [ "Product", "Drug" ], "name": "Moxifloxacin 0.5% & Hydroxypropyl Methylcellulose 0.25% Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/moxifloxacin-0-5-hydroxypropyl-methylcellulose-0-25-eye-drop-akp-069", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-069-moxifloxacin-0-5-hydroxypropyl-methylcel.webp", "description": "Viscosified fluoroquinolone eye drop incorporating HPMC ocular polymer to prolong pre-corneal antimicrobial contact time while soothing dry irritated conjunctiva. Active: Moxifloxacin Hydrochloride 0.5% w/v + Hydroxypropyl Methylcellulose (HPMC) 0.25% w/v (0.5% + 0.25% w/v). Indication: Infective conjunctivitis requiring enhanced ocular residence time and reduced surface irritation.", "sku": "AKP-069", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Ophthalmic Suspension / Drops", "activeIngredient": "Moxifloxacin Hydrochloride 0.5% w/v + Hydroxypropyl Methylcellulose (HPMC) 0.25% w/v", "strength": "0.5% + 0.25% w/v" } }, { "@type": "ListItem", "position": 97, "item": { "@type": [ "Product", "Drug" ], "name": "Aceclofenac 100mg & Paracetamol 325mg Tablets (Uncoated)", "url": "https://www.akumaenterprises-pharma.com/product/aceclofenac-100mg-paracetamol-325mg-tablets-uncoated-akp-005", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-005-aceclofenac-100mg-paracetamol-325mg-tabl.webp", "description": "Cost-effective uncoated oral analgesic tablet formulated for rapid disintegration in hospital tenders and high-turnover primary care relief of fever, soft-tissue inflammation, and orthopedic pain. Active: Aceclofenac IP + Paracetamol IP (100 mg + 325 mg). Indication: Acute inflammatory joint pain, myalgia, lumbago, and institutional general pain management.", "sku": "AKP-005", "category": "Tablets \u2014 Pain, Inflammation & NSAIDs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Uncoated Tablets", "activeIngredient": "Aceclofenac IP + Paracetamol IP", "strength": "100 mg + 325 mg" } }, { "@type": "ListItem", "position": 98, "item": { "@type": "Product", "name": "Kisspeptin-10 Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/kisspeptin-10-acetate-research-peptide-akp-rp-05", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-05-kisspeptin-10-acetate.webp", "description": "Endogenous KISS1-derived decapeptide tool compound utilized in neuroendocrine GnRH pulse-generator and reproductive signalling studies. Research area: Sex drive. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 388138-21-4) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Kisspeptin-10 Acetate (CAS 388138-21-4) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Sex drive.", "sku": "AKP-RP-05", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "388138-21-4" } }, { "@type": "ListItem", "position": 99, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 150 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-150-mg-akp-008-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-008-artesunate-150mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (150 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 150 mg (150 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-008-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 150 mg", "strength": "150 mg" } }, { "@type": "ListItem", "position": 100, "item": { "@type": [ "Product", "Drug" ], "name": "Magaldrate 400mg, Simethicone 20mg & Oxetacaine 10mg Oral Suspension (per 5ml)", "url": "https://www.akumaenterprises-pharma.com/product/magaldrate-400mg-simethicone-20mg-oxetacaine-10mg-oral-suspe-akp-036", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-036-magaldrate-400mg-simethicone-20mg-oxetac.webp", "description": "Topical mucosal anaesthetic-fortified antacid suspension providing instant local numbing relief from acute gastric burning while neutralizing acid and eliminating entrapped gas. Active: Magaldrate IP 400 mg + Simethicone IP 20 mg + Oxetacaine BP 10 mg (400 mg + 20 mg + 10 mg / 5 ml). Indication: Severe painful esophagitis, acute gastritis, peptic ulcer pain, and reflux-induced throat burn.", "sku": "AKP-036", "category": "Oral Liquids \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Antacid & Anaesthetic Suspension", "activeIngredient": "Magaldrate IP 400 mg + Simethicone IP 20 mg + Oxetacaine BP 10 mg", "strength": "400 mg + 20 mg + 10 mg / 5 ml" } }, { "@type": "ListItem", "position": 101, "item": { "@type": [ "Product", "Drug" ], "name": "Pantoprazole Sodium (eq. Pantoprazole 40mg) & Domperidone 30mg Capsules (Prolonged Release Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/pantoprazole-sodium-eq-pantoprazole-40mg-domperidone-30mg-ca-akp-013", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-013-pantoprazole-sodium-eq-pantoprazole-40mg.webp", "description": "Multi-particulate hard gelatin capsule combining enteric-coated pantoprazole 40 mg pellets with biphasic immediate- and sustained-release domperidone 30 mg pellets for once-daily 24-hour reflux control. Active: Pantoprazole Sodium (eq. 40 mg EC) + Domperidone IP 30 mg (10 mg IR + 20 mg SR Pellets) (40 mg + 30 mg (SR)). Indication: Severe GERD, nocturnal acid breakthrough, reflux esophagitis, and chronic functional dyspepsia.", "sku": "AKP-013", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Pellet Capsules", "activeIngredient": "Pantoprazole Sodium (eq. 40 mg EC) + Domperidone IP 30 mg (10 mg IR + 20 mg SR Pellets)", "strength": "40 mg + 30 mg (SR)" } }, { "@type": "ListItem", "position": 102, "item": { "@type": [ "Product", "Drug" ], "name": "Oxymetazoline HCl 0.05% w/v Nasal Spray", "url": "https://www.akumaenterprises-pharma.com/product/oxymetazoline-hcl-0-05-w-v-nasal-spray-akp-080", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-080-oxymetazoline-hcl-0-05-w-v-nasal-spray.webp", "description": "Twice-daily sustained-duration adult intranasal decongestant pump providing 12-hour clear nasal airflow and rapid sinus pressure relief. Active: Oxymetazoline Hydrochloride IP / USP 0.05% w/v (0.05% w/v). Indication: Adult nasal mucosal congestion in colds, hay fever, sinusitis, and Eustachian tube dysfunction.", "sku": "AKP-080", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Adult 12-Hour Nasal Spray", "activeIngredient": "Oxymetazoline Hydrochloride IP / USP 0.05% w/v", "strength": "0.05% w/v" } }, { "@type": "ListItem", "position": 103, "item": { "@type": [ "Product", "Drug" ], "name": "Clotrimazole 1.0% & Betamethasone Dipropionate 0.025% Cream", "url": "https://www.akumaenterprises-pharma.com/product/clotrimazole-1-0-betamethasone-dipropionate-0-025-cream-akp-030", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-030-clotrimazole-1-0-betamethasone-dipropion.webp", "description": "Broad-spectrum antifungal and moderate corticosteroid combination cream targeting superimposed fungal dermatophyte infections accompanied by marked localized inflammation and itching. Active: Clotrimazole IP 1.0% w/w + Betamethasone Dipropionate IP 0.025% w/w (1.0% + 0.025% w/w). Indication: Inflamed tinea cruris, tinea corporis, tinea pedis, and steroid-responsive eczematous mycoses.", "sku": "AKP-030", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Clotrimazole IP 1.0% w/w + Betamethasone Dipropionate IP 0.025% w/w", "strength": "1.0% + 0.025% w/w" } }, { "@type": "ListItem", "position": 104, "item": { "@type": [ "Product", "Drug" ], "name": "Nandrolone Decanoate 50mg Injection (per ml)", "url": "https://www.akumaenterprises-pharma.com/product/nandrolone-decanoate-50mg-injection-per-ml-akp-057", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-057-nandrolone-decanoate-50mg-injection-per.webp", "description": "High-strength 50 mg/ml sustained-release IM depot injection providing 3-week therapeutic anabolic bone mineralization and erythrocyte support under specialist endocrinology care. Active: Nandrolone Decanoate IP / BP 50 mg (in Sterile Arachis Oil Base) (50 mg / 1 ml). Indication: Severe postmenopausal osteoporosis, chronic corticosteroid-induced osteopenia, and refractory renal anemia.", "sku": "AKP-057", "category": "Liquid Injections \u2014 Endocrine & Supportive Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Oily Depot Injection Ampoule", "activeIngredient": "Nandrolone Decanoate IP / BP 50 mg (in Sterile Arachis Oil Base)", "strength": "50 mg / 1 ml" } }, { "@type": "ListItem", "position": 105, "item": { "@type": [ "Product", "Drug" ], "name": "Moxifloxacin 0.5% & Dexamethasone Sodium 0.1% Eye Drops", "url": "https://www.akumaenterprises-pharma.com/product/moxifloxacin-0-5-dexamethasone-sodium-0-1-eye-drops-akp-070", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-070-moxifloxacin-0-5-dexamethasone-sodium-0.webp", "description": "Synergistic fourth-generation fluoroquinolone and potent corticosteroid ophthalmic solution preventing secondary bacterial colonization during acute ocular inflammatory recovery. Active: Moxifloxacin Hydrochloride 0.5% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v (0.5% + 0.1% w/v). Indication: Post-operative cataract/ocular inflammation, steroid-responsive anterior uveitis, and severe bacterial blepharoconjunctivitis.", "sku": "AKP-070", "category": "Eye-Ear Drops \u2014 Ophthalmic & Otic Care", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Antibiotic-Steroid Eye Drops", "activeIngredient": "Moxifloxacin Hydrochloride 0.5% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v", "strength": "0.5% + 0.1% w/v" } }, { "@type": "ListItem", "position": 106, "item": { "@type": [ "Product", "Drug" ], "name": "Rabeprazole Sodium 20mg & Domperidone 10mg Tablets (Enteric Coated)", "url": "https://www.akumaenterprises-pharma.com/product/rabeprazole-sodium-20mg-domperidone-10mg-tablets-enteric-coa-akp-007", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-007-rabeprazole-sodium-20mg-domperidone-10mg.webp", "description": "Fast-onset enteric-coated proton pump inhibitor and dopamine D2 antagonist tablet engineered for predictable intragastric acid suppression and coordinated upper GI motility. Active: Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg (20 mg + 10 mg). Indication: Acid reflux esophagitis, hyperacidity, bloating, and non-ulcer dyspepsia.", "sku": "AKP-007", "category": "Tablets \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Tablets", "activeIngredient": "Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg", "strength": "20 mg + 10 mg" } }, { "@type": "ListItem", "position": 107, "item": { "@type": [ "Product", "Drug" ], "name": "Ganirelix Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/ganirelix-peptide-api-akp-api-06", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-06-ganirelix.webp", "description": "Synthetic GnRH antagonist decapeptide API indicated for controlled ovarian stimulation to prevent premature LH surges. Indicated for Prevention of premature LH surge. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 123246-29-7) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Ganirelix (CAS 123246-29-7) (Purity \u2265 99.0% (HPLC)). Indication: Prevention of premature LH surge.", "sku": "AKP-API-06", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Ganirelix (CAS 123246-29-7)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "123246-29-7" } }, { "@type": "ListItem", "position": 108, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 500mg & Sulbactam Sodium 250mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-500mg-sulbactam-sodium-250mg-injection-akp-046", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-046-ceftriaxone-sodium-500mg-sulbactam-sodiu.webp", "description": "Mid-dose sterile 2:1 ceftriaxone-sulbactam dry powder injection formulated for intermediate IM/IV escalation therapy in hospital outpatient and inpatient wards. Active: Ceftriaxone Sodium IP (eq. 500 mg) + Sulbactam Sodium IP (eq. 250 mg) (500 mg + 250 mg (750 mg)). Indication: Beta-lactamase-producing respiratory infections, complicated UTIs, and gynecological sepsis.", "sku": "AKP-046", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium IP (eq. 500 mg) + Sulbactam Sodium IP (eq. 250 mg)", "strength": "500 mg + 250 mg (750 mg)" } }, { "@type": "ListItem", "position": 109, "item": { "@type": [ "Product", "Drug" ], "name": "Sucralfate 1000mg & Oxetacaine 20mg Oral Suspension (per 10ml)", "url": "https://www.akumaenterprises-pharma.com/product/sucralfate-1000mg-oxetacaine-20mg-oral-suspension-per-10ml-akp-037", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-037-sucralfate-1000mg-oxetacaine-20mg-oral-s.webp", "description": "Ulcer-coating sucralfate suspension reinforced with oxetacaine topical anaesthetic to insulate exposed nerve endings from gastric acid while shielding mucosal tissue regeneration. Active: Sucralfate IP 1000 mg + Oxetacaine BP 20 mg (per 10 ml) (1000 mg + 20 mg / 10 ml). Indication: Painful gastric and duodenal ulcers, acute radiation/NSAID esophagitis, and burning epigastric distress.", "sku": "AKP-037", "category": "Oral Liquids \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Oral Cytoprotective Suspension", "activeIngredient": "Sucralfate IP 1000 mg + Oxetacaine BP 20 mg (per 10 ml)", "strength": "1000 mg + 20 mg / 10 ml" } }, { "@type": "ListItem", "position": 110, "item": { "@type": [ "Product", "Drug" ], "name": "Silodosin Capsules 8 mg", "url": "https://www.akumaenterprises-pharma.com/product/silodosin-capsules-8-mg-akp-078-sw", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-078-silodosin-8mg-capsules.webp", "description": "Precision-filled hard gelatin capsule containing uroselective alpha-1A adrenoceptor antagonist silodosin (8 mg) tailored for renal-adjusted (2 mg), standard (4 mg), or high-efficacy (8 mg) BPH regimens. Active: Silodosin 8 mg (8 mg). Indication: Dose-titrated symptomatic management of benign prostatic hyperplasia (BPH) and bladder outlet obstruction.", "sku": "AKP-078-SW", "category": "Capsules \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules", "activeIngredient": "Silodosin 8 mg", "strength": "8 mg" } }, { "@type": "ListItem", "position": 111, "item": { "@type": [ "Product", "Drug" ], "name": "Ventolin Inhaler (Salbutamol Metered Dose Inhaler 100mcg)", "url": "https://www.akumaenterprises-pharma.com/product/ventolin-inhaler-salbutamol-metered-dose-inhaler-100mcg-akp-097", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-097-ventolin-inhaler-salbutamol-metered-dose.webp", "description": "Pressurized metered-dose short-acting beta-2 agonist bronchodilator inhaler delivering 100 mcg salbutamol per actuation for rapid relief of acute bronchospasm, asthma, and COPD wheezing. Active: Salbutamol Sulfate BP / USP (Albuterol) (100mcg per actuation (200 metered doses)). Indication: Bronchospasm, acute asthma, COPD bronchoconstriction.", "sku": "AKP-097", "category": "Nasal Spray \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Metered Dose Inhaler (Pressurized Inhalation)", "activeIngredient": "Salbutamol Sulfate BP / USP (Albuterol)", "strength": "100mcg per actuation (200 metered doses)" } }, { "@type": "ListItem", "position": 112, "item": { "@type": [ "Product", "Drug" ], "name": "Candid Cream (Clotrimazole Topical Cream IP 1% w/w)", "url": "https://www.akumaenterprises-pharma.com/product/candid-cream-clotrimazole-topical-cream-ip-1-w-w-akp-098", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-098-candid-cream-clotrimazole-topical-cream.webp", "description": "Proven broad-spectrum topical imidazole antifungal cream formulated to eliminate dermatophytes, yeasts, and Malassezia skin infections including athlete's foot, jock itch, and ringworm. Active: Clotrimazole IP (1.0% w/w). Indication: Tinea pedis, candidiasis, dermatophytosis, fungal skin infections.", "sku": "AKP-098", "category": "Ointments & Creams \u2014 Dermatology & Topicals", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Topical Cream", "activeIngredient": "Clotrimazole IP", "strength": "1.0% w/w" } }, { "@type": "ListItem", "position": 113, "item": { "@type": [ "Product", "Drug" ], "name": "Artemether Injection 40 mg / ml", "url": "https://www.akumaenterprises-pharma.com/product/artemether-injection-40-mg-ml-akp-006-liq", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-006-liq-artemether-40mg-injection.webp", "description": "Ready-to-inject lipid-soluble artemisinin derivative (40 mg / ml) in USP Type I glass ampoules delivering rapid intra-erythrocytic schizonticidal action for ICU and rural malaria clinics. Active: Artemether 40 mg / ml (40 mg / ml). Indication: Severe chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria emergency care.", "sku": "AKP-006-LIQ", "category": "Liquid Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Intramuscular Liquid Injection Ampoule", "activeIngredient": "Artemether 40 mg / ml", "strength": "40 mg / ml" } }, { "@type": "ListItem", "position": 114, "item": { "@type": [ "Product", "Drug" ], "name": "Dapoxetine 30 mg & Tadalafil 10 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/dapoxetine-30-mg-tadalafil-10-mg-tablets-akp-104", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-104-dapoxetine-30mg-tadalafil-10mg-tablets.webp", "description": "Long-duration dual-action formulation uniting tadalafil (10 mg) with rapid-onset dapoxetine 30 mg for sustained hemodynamic response and improved ejaculatory control. Active: Dapoxetine 30 mg + Tadalafil 10 mg (30 mg + 10 mg). Indication: Co-existing erectile dysfunction and premature ejaculation requiring extended 36-hour therapeutic window.", "sku": "AKP-104", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Dapoxetine 30 mg + Tadalafil 10 mg", "strength": "30 mg + 10 mg" } }, { "@type": "ListItem", "position": 115, "item": { "@type": "Product", "name": "Epithalon Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/epithalon-research-peptide-akp-rp-06", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-06-epithalon.webp", "description": "Synthetic tetrapeptide (Ala-Glu-Asp-Gly) investigated in cellular senescence, telomerase activation, and circadian pineal assays. Research area: Anti-aging. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 307297-39-8) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Epithalon (CAS 307297-39-8) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Anti-aging.", "sku": "AKP-RP-06", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "307297-39-8" } }, { "@type": "ListItem", "position": 116, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 180 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-180-mg-akp-009-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-009-artesunate-180mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (180 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 180 mg (180 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-009-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 180 mg", "strength": "180 mg" } }, { "@type": "ListItem", "position": 117, "item": { "@type": [ "Product", "Drug" ], "name": "Rabeprazole Sodium 20mg & Domperidone 30mg Capsules (Sustained Release Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/rabeprazole-sodium-20mg-domperidone-30mg-capsules-sustained-akp-014", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-014-rabeprazole-sodium-20mg-domperidone-30mg.webp", "description": "Once-daily capsule delivering enteric-coated rabeprazole sodium alongside extended-release domperidone pellets for rapid acid-pH elevation and continuous antiemetic prokinetic action. Active: Rabeprazole Sodium IP 20 mg (EC) + Domperidone IP 30 mg (SR Pellets) (20 mg + 30 mg (SR)). Indication: Erosive GERD, laryngopharyngeal reflux, and acid-related upper GI motility disorders.", "sku": "AKP-014", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Pellet Capsules", "activeIngredient": "Rabeprazole Sodium IP 20 mg (EC) + Domperidone IP 30 mg (SR Pellets)", "strength": "20 mg + 30 mg (SR)" } }, { "@type": "ListItem", "position": 118, "item": { "@type": [ "Product", "Drug" ], "name": "Amikacin Sulphate 500mg Injection (per 2ml)", "url": "https://www.akumaenterprises-pharma.com/product/amikacin-sulphate-500mg-injection-per-2ml-akp-053", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-053-amikacin-sulphate-500mg-injection-per-2m.webp", "description": "Adult full-strength 500 mg/2 ml broad-spectrum bactericidal aminoglycoside injectable packaged in zero-leach borosilicate glass for hospital IM and slow IV infusion. Active: Amikacin Sulphate IP (eq. Amikacin 500 mg per 2 ml) (500 mg / 2 ml). Indication: Severe Pseudomonas, Klebsiella, and Acinetobacter bacteremia, ICU sepsis, and multidrug-resistant TB adjunct therapy.", "sku": "AKP-053", "category": "Liquid Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Liquid Injection Vial / Ampoule", "activeIngredient": "Amikacin Sulphate IP (eq. Amikacin 500 mg per 2 ml)", "strength": "500 mg / 2 ml" } }, { "@type": "ListItem", "position": 119, "item": { "@type": [ "Product", "Drug" ], "name": "Chloroquine Phosphate Tablets IP 250 mg", "url": "https://www.akumaenterprises-pharma.com/product/chloroquine-phosphate-tablets-ip-250-mg-akp-086-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-086-chloroquine-phosphate-250mg-tablets.webp", "description": "Compendial 4-aminoquinoline antimalarial and antiprotozoal tablet (250 mg chloroquine phosphate) supporting malaria radical cure protocols and hepatic amoebic abscess therapy. Active: Chloroquine Phosphate IP 250 mg (250 mg). Indication: Acute vivax, ovale, and chloroquine-susceptible malaria; extraintestinal hepatic amoebiasis.", "sku": "AKP-086-MAL", "category": "Tablets \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Uncoated / Film-Coated Tablets", "activeIngredient": "Chloroquine Phosphate IP 250 mg", "strength": "250 mg" } }, { "@type": "ListItem", "position": 120, "item": { "@type": [ "Product", "Drug" ], "name": "Lanreotide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/lanreotide-peptide-api-akp-api-07", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-07-lanreotide.webp", "description": "Long-acting somatostatin analogue octapeptide API for acromegaly and gastroenteropancreatic neuroendocrine tumour depot preparations. Indicated for Acromegaly, TSH-secreting pituitary adenoma. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 108736-35-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Lanreotide (CAS 108736-35-2) (Purity \u2265 99.0% (HPLC)). Indication: Acromegaly, TSH-secreting pituitary adenoma.", "sku": "AKP-API-07", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Lanreotide (CAS 108736-35-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "108736-35-2" } }, { "@type": "ListItem", "position": 121, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 750mg & Sulbactam Sodium 375mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-750mg-sulbactam-sodium-375mg-injection-akp-047", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-047-ceftriaxone-sodium-750mg-sulbactam-sodiu.webp", "description": "Intermediate 1.125 g parenteral cephalosporin/beta-lactamase inhibitor combination vial supporting broad aerobic-anaerobic empirical antimicrobial coverage. Active: Ceftriaxone Sodium IP (eq. 750 mg) + Sulbactam Sodium IP (eq. 375 mg) (750 mg + 375 mg (1.125 g)). Indication: Moderate-to-severe intra-abdominal infections, lower respiratory tract infections, and post-operative sepsis.", "sku": "AKP-047", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium IP (eq. 750 mg) + Sulbactam Sodium IP (eq. 375 mg)", "strength": "750 mg + 375 mg (1.125 g)" } }, { "@type": "ListItem", "position": 122, "item": { "@type": [ "Product", "Drug" ], "name": "Herbal Sex Booster Capsules", "url": "https://www.akumaenterprises-pharma.com/product/herbal-sex-booster-capsules-akp-030-ayur", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-030-ayur-herbal-sex-booster-capsules.webp", "description": "Standardized Ayurvedic proprietary herbal blend encapsulated under GMP quality controls to support physiological vigor, reproductive wellness, and physical endurance. Active: Ayurvedic Proprietary Formula (Standardized Herbal Extract). Indication: Male vitality, stamina support, adaptogenic stress resilience, and sexual wellness.", "sku": "AKP-030-AYUR", "category": "Capsules \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Hard Gelatin Capsules (Ayurvedic Formulation)", "activeIngredient": "Ayurvedic Proprietary Formula", "strength": "Standardized Herbal Extract" } }, { "@type": "ListItem", "position": 123, "item": { "@type": [ "Product", "Drug" ], "name": "Artemether Injection 80 mg / ml", "url": "https://www.akumaenterprises-pharma.com/product/artemether-injection-80-mg-ml-akp-007-liq", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-007-liq-artemether-80mg-injection.webp", "description": "Ready-to-inject lipid-soluble artemisinin derivative (80 mg / ml) in USP Type I glass ampoules delivering rapid intra-erythrocytic schizonticidal action for ICU and rural malaria clinics. Active: Artemether 80 mg / ml (80 mg / ml). Indication: Severe chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria emergency care.", "sku": "AKP-007-LIQ", "category": "Liquid Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Intramuscular Liquid Injection Ampoule", "activeIngredient": "Artemether 80 mg / ml", "strength": "80 mg / ml" } }, { "@type": "ListItem", "position": 124, "item": { "@type": [ "Product", "Drug" ], "name": "Dapagliflozin 10 mg & Metformin HCl 500 mg ER Tablets", "url": "https://www.akumaenterprises-pharma.com/product/dapagliflozin-10-mg-metformin-hcl-500-mg-er-tablets-akp-101", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-101-dapagliflozin-10mg-metformin-500mg-er-tablets.webp", "description": "Once-daily insulin-independent SGLT2 inhibitor dapagliflozin 10 mg combined with extended-release metformin HCl (500 mg) promoting urinary glucose excretion alongside hepatic gluconeogenesis suppression. Active: Dapagliflozin 10 mg + Metformin HCl 500 mg (ER) (10 mg + 500 mg (ER)). Indication: Type 2 diabetes mellitus glycemic control, cardiovascular-renal risk reduction, and weight-favorable glucose lowering.", "sku": "AKP-101", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Extended-Release Bilayer Tablets", "activeIngredient": "Dapagliflozin 10 mg + Metformin HCl 500 mg (ER)", "strength": "10 mg + 500 mg (ER)" } }, { "@type": "ListItem", "position": 125, "item": { "@type": "Product", "name": "GHK-Cu Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ghk-cu-research-peptide-akp-rp-07", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-07-ghk-cu.webp", "description": "Chelated glycyl-L-histidyl-L-lysine copper(II) tripeptide complex for extracellular matrix remodeling and dermal research assays. Research area: Skincare (Copper Peptide). Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 49557-75-7) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: GHK-Cu (CAS 49557-75-7) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Skincare (Copper Peptide).", "sku": "AKP-RP-07", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "49557-75-7" } }, { "@type": "ListItem", "position": 126, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 210 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-210-mg-akp-010-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-010-artesunate-210mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (210 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 210 mg (210 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-010-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 210 mg", "strength": "210 mg" } }, { "@type": "ListItem", "position": 127, "item": { "@type": [ "Product", "Drug" ], "name": "Rabeprazole Sodium 20mg & Levosulpiride 75mg Capsules (Sustained Release Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/rabeprazole-sodium-20mg-levosulpiride-75mg-capsules-sustaine-akp-015", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-015-rabeprazole-sodium-20mg-levosulpiride-75.webp", "description": "Advanced prokinetic-PPI capsule pairing enteric-coated rabeprazole with sustained-release levosulpiride 75 mg to enhance lower esophageal sphincter tone and accelerate antroduodenal coordination. Active: Rabeprazole Sodium IP 20 mg (EC) + Levosulpiride 75 mg (SR Pellets) (20 mg + 75 mg (SR)). Indication: Refractory GERD, diabetic gastroparesis, and irritable bowel-associated upper dyspepsia.", "sku": "AKP-015", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Pellet Capsules", "activeIngredient": "Rabeprazole Sodium IP 20 mg (EC) + Levosulpiride 75 mg (SR Pellets)", "strength": "20 mg + 75 mg (SR)" } }, { "@type": "ListItem", "position": 128, "item": { "@type": [ "Product", "Drug" ], "name": "\u03b1-\u03b2 Arteether Injection 150 mg / 2 ml", "url": "https://www.akumaenterprises-pharma.com/product/arteether-injection-150-mg-2-ml-akp-009-liq", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-009-liq-alpha-beta-arteether-150mg-2ml-injection.webp", "description": "Semi-synthetic ethyl-ether artemisinin derivative (150 mg / 2 ml) formulated in sterile oily vehicle for sustained 24-hour once-daily intramuscular eradication of cerebral malaria parasites. Active: \u03b1-\u03b2 Arteether 150 mg / 2 ml (150 mg / 2 ml). Indication: Severe and cerebral P. falciparum malaria and chloroquine-resistant vivax/falciparum co-infections.", "sku": "AKP-009-LIQ", "category": "Liquid Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Intramuscular Liquid Injection Ampoule", "activeIngredient": "\u03b1-\u03b2 Arteether 150 mg / 2 ml", "strength": "150 mg / 2 ml" } }, { "@type": "ListItem", "position": 129, "item": { "@type": [ "Product", "Drug" ], "name": "Cefixime 200mg Film-Coated Tablets IP", "url": "https://www.akumaenterprises-pharma.com/product/cefixime-200mg-film-coated-tablets-ip-akp-100", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-100-cefixime-200mg-film-coated-tablets-ip.webp", "description": "Broad-spectrum oral third-generation cephalosporin film-coated tablet providing potent bactericidal coverage against community respiratory tract pathogens, enteric fever, and uncomplicated UTIs. Active: Cefixime IP (Trihydrate) (200mg). Indication: Upper & lower respiratory tract infections, typhoid, uncomplicated UTI.", "sku": "AKP-100", "category": "Tablets \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Cefixime IP (Trihydrate)", "strength": "200mg" } }, { "@type": "ListItem", "position": 130, "item": { "@type": [ "Product", "Drug" ], "name": "Abaloparatide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/abaloparatide-peptide-api-akp-api-08", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-08-abaloparatide.webp", "description": "Selective PTHrP (PTH1R) agonist peptide API developed for osteoanabolic therapy in postmenopausal osteoporosis. Indicated for Osteoporosis. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 247062-33-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Abaloparatide (CAS 247062-33-5) (Purity \u2265 99.0% (HPLC)). Indication: Osteoporosis.", "sku": "AKP-API-08", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Abaloparatide (CAS 247062-33-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "247062-33-5" } }, { "@type": "ListItem", "position": 131, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 1000mg & Sulbactam Sodium 500mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-1000mg-sulbactam-sodium-500mg-injection-akp-048", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-048-ceftriaxone-sodium-1000mg-sulbactam-sodi.webp", "description": "Full-strength 1.5 g critical-care injectable antibiotic vial protecting ceftriaxone against enzymatic hydrolysis by ESBL-producing gram-negative hospital pathogens. Active: Ceftriaxone Sodium USP (eq. 1000 mg) + Sulbactam Sodium USP (eq. 500 mg) (1000 mg + 500 mg (1.5 g)). Indication: Severe nosocomial pneumonia, sepsis, bacterial meningitis, bone/joint infections, and surgical prophylaxis.", "sku": "AKP-048", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium USP (eq. 1000 mg) + Sulbactam Sodium USP (eq. 500 mg)", "strength": "1000 mg + 500 mg (1.5 g)" } }, { "@type": "ListItem", "position": 132, "item": { "@type": [ "Product", "Drug" ], "name": "Cinitapride 3mg (Sustained Release) & Pantoprazole Sodium (eq. Pantoprazole 40mg) Capsules", "url": "https://www.akumaenterprises-pharma.com/product/cinitapride-3mg-sustained-release-pantoprazole-sodium-eq-pan-akp-016", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-016-cinitapride-3mg-sustained-release-pantop.webp", "description": "5-HT4 receptor agonist prokinetic and proton pump inhibitor capsule engineered to stimulate acetylcholine-mediated GI peristalsis while suppressing 24-hour gastric acid secretion. Active: Cinitapride Hydrogen Tartrate 3 mg (SR) + Pantoprazole Sodium (eq. 40 mg EC) (3 mg (SR) + 40 mg). Indication: Motility-associated GERD, delayed gastric emptying, and non-ulcer functional dyspepsia.", "sku": "AKP-016", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Pellet Capsules", "activeIngredient": "Cinitapride Hydrogen Tartrate 3 mg (SR) + Pantoprazole Sodium (eq. 40 mg EC)", "strength": "3 mg (SR) + 40 mg" } }, { "@type": "ListItem", "position": 133, "item": { "@type": [ "Product", "Drug" ], "name": "Mucolite Tablets (Ambroxol Hydrochloride 30mg)", "url": "https://www.akumaenterprises-pharma.com/product/mucolite-tablets-ambroxol-hydrochloride-30mg-akp-099", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-099-mucolite-tablets-ambroxol-hydrochloride.webp", "description": "Systemic secretolytic mucolytic tablet thinning tenacious bronchial secretions and activating mucociliary clearance in productive cough, acute bronchitis, and exacerbations of COPD. Active: Ambroxol Hydrochloride IP (30mg). Indication: Productive cough, chronic bronchitis, bronchiectasis, secretolytic therapy.", "sku": "AKP-099", "category": "Tablets \u2014 Respiratory & Allergy", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Ambroxol Hydrochloride IP", "strength": "30mg" } }, { "@type": "ListItem", "position": 134, "item": { "@type": "Product", "name": "KPV Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/kpv-research-peptide-akp-rp-08", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-08-kpv.webp", "description": "C-terminal alpha-MSH tripeptide fragment (Lys-Pro-Val) examined in NF-\u03baB anti-inflammatory and mucosal barrier models. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 243152-09-6) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: KPV (CAS 243152-09-6) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-08", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "243152-09-6" } }, { "@type": "ListItem", "position": 135, "item": { "@type": [ "Product", "Drug" ], "name": "Artesunate for Injection 240 mg", "url": "https://www.akumaenterprises-pharma.com/product/artesunate-for-injection-240-mg-akp-011-mal", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-011-artesunate-240mg-injection.webp", "description": "WHO first-line parenteral artemisinin-derivative sterile vial (240 mg artesunate with co-packed sodium bicarbonate activator & saline diluent) engineered for life-saving IV/IM emergency malaria treatment across endemic regions. Active: Artesunate 240 mg (240 mg). Indication: Severe and cerebral Plasmodium falciparum malaria requiring rapid parenteral parasitemia clearance.", "sku": "AKP-011-MAL", "category": "Dry Powder Injections \u2014 Antimalarials Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial + Co-packed Diluent", "activeIngredient": "Artesunate 240 mg", "strength": "240 mg" } }, { "@type": "ListItem", "position": 136, "item": { "@type": [ "Product", "Drug" ], "name": "Rabeprazole Sodium 20mg & Domperidone 10mg Capsules (Coated Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/rabeprazole-sodium-20mg-domperidone-10mg-capsules-coated-pel-akp-019", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-019-rabeprazole-sodium-20mg-domperidone-10mg.webp", "description": "Dual-pellet hard gelatin capsule engineered for stable dissolution kinetics and reliable acid neutralization in chronic gastritis and gastroesophageal reflux. Active: Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg (Coated Pellets) (20 mg + 10 mg). Indication: Postprandial heartburn, NSAID-induced gastropathy, and acid reflux with nausea.", "sku": "AKP-019", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Pellet Capsules", "activeIngredient": "Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg (Coated Pellets)", "strength": "20 mg + 10 mg" } }, { "@type": "ListItem", "position": 137, "item": { "@type": [ "Product", "Drug" ], "name": "Pantoprazole Sodium (eq. Pantoprazole 40mg) Tablets (Enteric Coated)", "url": "https://www.akumaenterprises-pharma.com/product/pantoprazole-sodium-eq-pantoprazole-40mg-tablets-enteric-coa-akp-008", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-008-pantoprazole-sodium-eq-pantoprazole-40mg.webp", "description": "Standard 40 mg delayed-release gastro-resistant tablet delivering sustained H+/K+-ATPase blockade for healing peptic ulcers and preventing NSAID-induced mucosal injury. Active: Pantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg) (40 mg). Indication: Erosive esophagitis, duodenal and gastric ulcers, Zollinger-Ellison syndrome, and H. pylori eradication regimens.", "sku": "AKP-008", "category": "Tablets \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Tablets", "activeIngredient": "Pantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg)", "strength": "40 mg" } }, { "@type": "ListItem", "position": 138, "item": { "@type": [ "Product", "Drug" ], "name": "Etelcalcetide HCl Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/etelcalcetide-hcl-peptide-api-akp-api-09", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-09-etelcalcetide-hcl.webp", "description": "Calcimimetic D-amino-acid peptide API for intravenous management of secondary hyperparathyroidism (SHPT) in haemodialysis patients. Indicated for Secondary hyperparathyroidism (SHPT). Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 1334237-71-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Etelcalcetide HCl (CAS 1334237-71-6) (Purity \u2265 99.0% (HPLC)). Indication: Secondary hyperparathyroidism (SHPT).", "sku": "AKP-API-09", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Etelcalcetide HCl (CAS 1334237-71-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "1334237-71-6" } }, { "@type": "ListItem", "position": 139, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 250mg & Tazobactam Sodium 31.25mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-250mg-tazobactam-sodium-31-25mg-injection-akp-049", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-049-ceftriaxone-sodium-250mg-tazobactam-sodi.webp", "description": "8:1 fixed-ratio paediatric ceftriaxone-tazobactam sterile vial offering superior irreversible beta-lactamase inhibition against stubborn ESBL and AmpC-expressing organisms. Active: Ceftriaxone Sodium IP (eq. 250 mg) + Tazobactam Sodium IP (eq. 31.25 mg) (250 mg + 31.25 mg). Indication: Paediatric resistant respiratory, urinary, and bloodstream infections caused by beta-lactamase pathogens.", "sku": "AKP-049", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium IP (eq. 250 mg) + Tazobactam Sodium IP (eq. 31.25 mg)", "strength": "250 mg + 31.25 mg" } }, { "@type": "ListItem", "position": 140, "item": { "@type": [ "Product", "Drug" ], "name": "Rabeprazole Sodium 20mg & Itopride Hydrochloride 150mg Capsules (Sustained Release Pellets)", "url": "https://www.akumaenterprises-pharma.com/product/rabeprazole-sodium-20mg-itopride-hydrochloride-150mg-capsule-akp-020", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-020-rabeprazole-sodium-20mg-itopride-hydroch.webp", "description": "Synergistic PPI and acetylcholinesterase/D2-receptor prokinetic sustained-release capsule restoring physiological gastric motility without QT-prolongation risk. Active: Rabeprazole Sodium IP 20 mg + Itopride Hydrochloride 150 mg (SR Pellets) (20 mg + 150 mg (SR)). Indication: Functional dyspepsia, chronic GERD, early satiety, and bloating syndromes.", "sku": "AKP-020", "category": "Capsules \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Pellet Capsules", "activeIngredient": "Rabeprazole Sodium IP 20 mg + Itopride Hydrochloride 150 mg (SR Pellets)", "strength": "20 mg + 150 mg (SR)" } }, { "@type": "ListItem", "position": 141, "item": { "@type": [ "Product", "Drug" ], "name": "Dapoxetine 30 mg & Tadalafil 20 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/dapoxetine-30-mg-tadalafil-20-mg-tablets-akp-105", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-105-dapoxetine-30mg-tadalafil-20mg-tablets.webp", "description": "Long-duration dual-action formulation uniting tadalafil (20 mg) with rapid-onset dapoxetine 30 mg for sustained hemodynamic response and improved ejaculatory control. Active: Dapoxetine 30 mg + Tadalafil 20 mg (30 mg + 20 mg). Indication: Co-existing erectile dysfunction and premature ejaculation requiring extended 36-hour therapeutic window.", "sku": "AKP-105", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Dapoxetine 30 mg + Tadalafil 20 mg", "strength": "30 mg + 20 mg" } }, { "@type": "ListItem", "position": 142, "item": { "@type": "Product", "name": "LL-37 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ll-37-research-peptide-akp-rp-09", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-09-ll-37.webp", "description": "Human cathelicidin antimicrobial 37-amino-acid peptide investigated for innate host-defense and biofilm-disruption assays. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 154947-66-7) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: LL-37 (CAS 154947-66-7) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-09", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "154947-66-7" } }, { "@type": "ListItem", "position": 143, "item": { "@type": [ "Product", "Drug" ], "name": "Ceftriaxone Sodium 1000mg & Tazobactam Sodium 125mg Injection", "url": "https://www.akumaenterprises-pharma.com/product/ceftriaxone-sodium-1000mg-tazobactam-sodium-125mg-injection-akp-050", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-050-ceftriaxone-sodium-1000mg-tazobactam-sod.webp", "description": "High-efficacy 8:1 ICU parenteral vial combining 1 g ceftriaxone with 125 mg tazobactam for potent gram-negative and anaerobe clearance in complicated clinical infections. Active: Ceftriaxone Sodium IP (eq. 1000 mg) + Tazobactam Sodium IP (eq. 125 mg) (1000 mg + 125 mg (1.125 g)). Indication: Severe hospital-acquired pneumonia, multidrug-resistant typhoid, pelvic infections, and systemic bacteremia.", "sku": "AKP-050", "category": "Dry Powder Injections \u2014 Anti-Infectives & Antibiotics", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sterile Dry Powder Injection Vial", "activeIngredient": "Ceftriaxone Sodium IP (eq. 1000 mg) + Tazobactam Sodium IP (eq. 125 mg)", "strength": "1000 mg + 125 mg (1.125 g)" } }, { "@type": "ListItem", "position": 144, "item": { "@type": [ "Product", "Drug" ], "name": "Dapagliflozin Tablets 10 mg", "url": "https://www.akumaenterprises-pharma.com/product/dapagliflozin-tablets-10-mg-akp-102", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-102-dapagliflozin-10mg-tablets.webp", "description": "Highly selective SGLT2 inhibitor tablet (10 mg) reducing renal glucose reabsorption, lowering HbA1c without hypoglycemia, and conferring proven cardiorenal protection. Active: Dapagliflozin 10 mg (10 mg). Indication: Type 2 diabetes mellitus (monotherapy or add-on), HFrEF heart failure hospitalization reduction, and CKD progression slowing.", "sku": "AKP-102", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Dapagliflozin 10 mg", "strength": "10 mg" } }, { "@type": "ListItem", "position": 145, "item": { "@type": [ "Product", "Drug" ], "name": "Difelikefalin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/difelikefalin-peptide-api-akp-api-10", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-10-difelikefalin.webp", "description": "Peripherally selective kappa-opioid receptor agonist peptide API for moderate-to-severe pruritus associated with chronic kidney disease. Indicated for CKD-associated pruritus. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 1024828-77-0) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Difelikefalin (CAS 1024828-77-0) (Purity \u2265 99.0% (HPLC)). Indication: CKD-associated pruritus.", "sku": "AKP-API-10", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Difelikefalin (CAS 1024828-77-0)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "1024828-77-0" } }, { "@type": "ListItem", "position": 146, "item": { "@type": [ "Product", "Drug" ], "name": "Pantoprazole (eq. 40mg) & Domperidone 10mg Tablets (Enteric Coated)", "url": "https://www.akumaenterprises-pharma.com/product/pantoprazole-eq-40mg-domperidone-10mg-tablets-enteric-coated-akp-009", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-009-pantoprazole-eq-40mg-domperidone-10mg-ta.webp", "description": "Full-strength acid-suppressive and prokinetic enteric-coated tablet designed for moderate-to-severe reflux esophagitis accompanied by postprandial fullness, belching, and nausea. Active: Pantoprazole Sodium (eq. Pantoprazole 40 mg) + Domperidone IP 10 mg (40 mg + 10 mg). Indication: Refractory GERD, acid regurgitation, epigastric heartburn, and dysmotility-related dyspepsia.", "sku": "AKP-009", "category": "Tablets \u2014 Gastroenterology & PPIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Enteric-Coated Tablets", "activeIngredient": "Pantoprazole Sodium (eq. Pantoprazole 40 mg) + Domperidone IP 10 mg", "strength": "40 mg + 10 mg" } }, { "@type": "ListItem", "position": 147, "item": { "@type": "Product", "name": "Ipamorelin Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ipamorelin-acetate-research-peptide-akp-rp-10", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-10-ipamorelin-acetate.webp", "description": "Selective pentapeptide ghrelin/GHS-R1a secretagogue evaluated in pulsatile somatotropic signalling research. Research area: Muscle. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 170851-70-4) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Ipamorelin Acetate (CAS 170851-70-4) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Muscle.", "sku": "AKP-RP-10", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "170851-70-4" } }, { "@type": "ListItem", "position": 148, "item": { "@type": [ "Product", "Drug" ], "name": "Sildenafil Citrate Tablets 100 mg", "url": "https://www.akumaenterprises-pharma.com/product/sildenafil-citrate-tablets-100-mg-akp-340", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-340-sildenafil-citrate-100mg-tablets.webp", "description": "Compendial selective phosphodiesterase type-5 (PDE5) inhibitor film-coated tablet (100 mg) restoring nitric-oxide-driven penile blood flow within 30\u201360 minutes under sexual stimulation. Active: Sildenafil Citrate IP 100 mg (100 mg). Indication: Erectile dysfunction (ED) via cGMP-mediated corpus cavernosum smooth muscle relaxation.", "sku": "AKP-340", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Sildenafil Citrate IP 100 mg", "strength": "100 mg" } }, { "@type": "ListItem", "position": 149, "item": { "@type": [ "Product", "Drug" ], "name": "Dasiglucagon Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/dasiglucagon-peptide-api-akp-api-11", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-11-dasiglucagon.webp", "description": "Stable aqueous-ready glucagon analogue peptide API for rapid rescue therapy in severe insulin-induced hypoglycaemia. Indicated for Severe hypoglycaemia. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 1544300-84-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Dasiglucagon (CAS 1544300-84-6) (Purity \u2265 99.0% (HPLC)). Indication: Severe hypoglycaemia.", "sku": "AKP-API-11", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Dasiglucagon (CAS 1544300-84-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "1544300-84-6" } }, { "@type": "ListItem", "position": 150, "item": { "@type": [ "Product", "Drug" ], "name": "Gliclazide Extended Release Tablets 80 mg", "url": "https://www.akumaenterprises-pharma.com/product/gliclazide-extended-release-tablets-80-mg-akp-166", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-166-gliclazide-80mg-er-tablets.webp", "description": "Second-generation pancreatic beta-cell selective sulfonylurea extended-release tablet (80 mg) restoring physiological first-phase insulin secretion with lower nocturnal hypoglycemia risk. Active: Gliclazide 80 mg (ER) (80 mg (ER)). Indication: Non-insulin-dependent Type 2 diabetes mellitus uncontrolled by diet and exercise alone.", "sku": "AKP-166", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Extended-Release Tablets", "activeIngredient": "Gliclazide 80 mg (ER)", "strength": "80 mg (ER)" } }, { "@type": "ListItem", "position": 151, "item": { "@type": "Product", "name": "MOTS-C Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/mots-c-research-peptide-akp-rp-11", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-11-mots-c.webp", "description": "16-amino-acid mitochondrial-derived open-reading-frame peptide (12S rRNA) studied in AMPK activation and metabolic homeostasis research. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 1627580-64-6) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: MOTS-C (CAS 1627580-64-6) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-11", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "1627580-64-6" } }, { "@type": "ListItem", "position": 152, "item": { "@type": [ "Product", "Drug" ], "name": "Sildenafil Citrate Tablets 50 mg", "url": "https://www.akumaenterprises-pharma.com/product/sildenafil-citrate-tablets-50-mg-akp-341", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-341-sildenafil-citrate-50mg-tablets.webp", "description": "Compendial selective phosphodiesterase type-5 (PDE5) inhibitor film-coated tablet (50 mg) restoring nitric-oxide-driven penile blood flow within 30\u201360 minutes under sexual stimulation. Active: Sildenafil Citrate IP 50 mg (50 mg). Indication: Erectile dysfunction (ED) via cGMP-mediated corpus cavernosum smooth muscle relaxation.", "sku": "AKP-341", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Sildenafil Citrate IP 50 mg", "strength": "50 mg" } }, { "@type": "ListItem", "position": 153, "item": { "@type": [ "Product", "Drug" ], "name": "Glucagon HCl Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/glucagon-hcl-peptide-api-akp-api-12", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-12-glucagon-hcl.webp", "description": "Recombinant/synthetic 29-amino-acid pancreatic hormone peptide API for acute hypoglycaemia emergency injection kits. Indicated for Hypoglycaemia. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 16941-32-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Glucagon HCl (CAS 16941-32-5) (Purity \u2265 99.0% (HPLC)). Indication: Hypoglycaemia.", "sku": "AKP-API-12", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Glucagon HCl (CAS 16941-32-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "16941-32-5" } }, { "@type": "ListItem", "position": 154, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride Tablets IP 1 mg", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-tablets-ip-1-mg-akp-167", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-167-glimepiride-1mg-tablets.webp", "description": "Once-daily modern sulfonylurea oral hypoglycemic tablet (1 mg) delivering predictable 24-hour fasting and postprandial blood glucose reduction. Active: Glimepiride IP 1 mg (1 mg). Indication: Type 2 diabetes mellitus glycemic control via enhanced endogenous insulin release and peripheral sensitivity.", "sku": "AKP-167", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Uncoated Scored Tablets", "activeIngredient": "Glimepiride IP 1 mg", "strength": "1 mg" } }, { "@type": "ListItem", "position": 155, "item": { "@type": "Product", "name": "PE 22-28 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/pe-22-28-research-peptide-akp-rp-12", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-12-pe-22-28.webp", "description": "Synthetic TREK-1 potassium channel antagonist heptapeptide studied in neurobiology and behavioral pharmacology models. Research area: Anti-infection. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 1801959-12-5) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: PE 22-28 (CAS 1801959-12-5) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Anti-infection.", "sku": "AKP-RP-12", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "1801959-12-5" } }, { "@type": "ListItem", "position": 156, "item": { "@type": [ "Product", "Drug" ], "name": "Sildenafil Citrate 50 mg & Dapoxetine 30 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/sildenafil-citrate-50-mg-dapoxetine-30-mg-tablets-akp-342", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-342-sildenafil-citrate-50mg-dapoxetine-30mg-tablets.webp", "description": "Dual-mechanism male sexual wellness tablet combining selective PDE5 vasodilator Sildenafil Citrate 50 mg & Dapoxetine 30 mg with rapid-acting SSRI dapoxetine 30 mg to enhance erectile rigidity and ejaculatory latency. Active: Sildenafil Citrate 50 mg + Dapoxetine 30 mg (50 mg + 30 mg). Indication: Simultaneous treatment of erectile dysfunction (ED) and premature ejaculation (PE) in adult men.", "sku": "AKP-342", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Sildenafil Citrate 50 mg + Dapoxetine 30 mg", "strength": "50 mg + 30 mg" } }, { "@type": "ListItem", "position": 157, "item": { "@type": [ "Product", "Drug" ], "name": "Cagrilintide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/cagrilintide-peptide-api-akp-api-13", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-13-cagrilintide.webp", "description": "Long-acting amylin analogue peptide API developed for combination metabolic, glycaemic, and obesity therapy pipelines. Indicated for T2DM, Obesity. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 1415456-99-3) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Cagrilintide (CAS 1415456-99-3) (Purity \u2265 99.0% (HPLC)). Indication: T2DM, Obesity.", "sku": "AKP-API-13", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Cagrilintide (CAS 1415456-99-3)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "1415456-99-3" } }, { "@type": "ListItem", "position": 158, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 1 mg & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-1-mg-pioglitazone-15-mg-tablets-akp-168", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-168-glimepiride-1mg-pioglitazone-15mg-tablets.webp", "description": "Dual-mechanism oral antidiabetic tablet pairing 1 mg glimepiride insulin secretagogue action with 15 mg pioglitazone PPAR-gamma insulin sensitization. Active: Glimepiride 1 mg + Pioglitazone 15 mg (1 mg + 15 mg). Indication: Type 2 diabetes with pronounced insulin resistance uncontrolled on monotherapy.", "sku": "AKP-168", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Combo Tablets", "activeIngredient": "Glimepiride 1 mg + Pioglitazone 15 mg", "strength": "1 mg + 15 mg" } }, { "@type": "ListItem", "position": 159, "item": { "@type": "Product", "name": "PT-141 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/pt-141-research-peptide-akp-rp-13", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-13-pt-141.webp", "description": "Cyclic heptapeptide melanocortin MC3R/MC4R receptor agonist (bremelanotide research analogue) used in melanocortin pathway assays. Research area: Sex drive. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 189691-06-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: PT-141 (CAS 189691-06-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Sex drive.", "sku": "AKP-RP-13", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "189691-06-3" } }, { "@type": "ListItem", "position": 160, "item": { "@type": [ "Product", "Drug" ], "name": "Tadalafil Tablets 10 mg", "url": "https://www.akumaenterprises-pharma.com/product/tadalafil-tablets-10-mg-akp-350", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-350-tadalafil-10mg-tablets.webp", "description": "Long-half-life PDE5 inhibitor tablet (10 mg) delivering prolonged 36-hour erectile responsiveness with minimal food-absorption interference. Active: Tadalafil IP 10 mg (10 mg). Indication: Erectile dysfunction (ED) and symptomatic benign prostatic hyperplasia (BPH).", "sku": "AKP-350", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Tadalafil IP 10 mg", "strength": "10 mg" } }, { "@type": "ListItem", "position": 161, "item": { "@type": [ "Product", "Drug" ], "name": "Exenatide Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/exenatide-acetate-peptide-api-akp-api-14", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-14-exenatide-acetate.webp", "description": "Incretin-mimetic 39-amino-acid GLP-1 receptor agonist peptide API for glycaemic regulation in type 2 diabetes mellitus. Indicated for T2DM. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 141732-76-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Exenatide Acetate (CAS 141732-76-5) (Purity \u2265 99.0% (HPLC)). Indication: T2DM.", "sku": "AKP-API-14", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Exenatide Acetate (CAS 141732-76-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "141732-76-5" } }, { "@type": "ListItem", "position": 162, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 1 mg & Metformin 500 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-1-mg-metformin-500-mg-tablets-akp-169", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-169-glimepiride-1mg-metformin-500mg-tablets.webp", "description": "Foundational dual oral hypoglycemic combination uniting 1 mg glimepiride beta-cell insulin stimulation with 500 mg metformin hepatic glucose-output inhibition. Active: Glimepiride 1 mg + Metformin 500 mg (1 mg + 500 mg). Indication: Type 2 diabetes mellitus poorly controlled on either metformin or sulfonylurea monotherapy.", "sku": "AKP-169", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Bilayer / Film-Coated Tablets", "activeIngredient": "Glimepiride 1 mg + Metformin 500 mg", "strength": "1 mg + 500 mg" } }, { "@type": "ListItem", "position": 163, "item": { "@type": "Product", "name": "Selank Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/selank-acetate-research-peptide-akp-rp-14", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-14-selank-acetate.webp", "description": "Synthetic tuftsin-analogue heptapeptide investigated for GABAergic modulation and anxiolytic neurochemical pathways. Research area: Cognition. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 129954-34-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Selank Acetate (CAS 129954-34-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Cognition.", "sku": "AKP-RP-14", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "129954-34-3" } }, { "@type": "ListItem", "position": 164, "item": { "@type": [ "Product", "Drug" ], "name": "Tadalafil Tablets 20 mg", "url": "https://www.akumaenterprises-pharma.com/product/tadalafil-tablets-20-mg-akp-351", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-351-tadalafil-20mg-tablets.webp", "description": "Long-half-life PDE5 inhibitor tablet (20 mg) delivering prolonged 36-hour erectile responsiveness with minimal food-absorption interference. Active: Tadalafil IP 20 mg (20 mg). Indication: Erectile dysfunction (ED) and symptomatic benign prostatic hyperplasia (BPH).", "sku": "AKP-351", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Tadalafil IP 20 mg", "strength": "20 mg" } }, { "@type": "ListItem", "position": 165, "item": { "@type": [ "Product", "Drug" ], "name": "Vosoritide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/vosoritide-peptide-api-akp-api-15", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-15-vosoritide.webp", "description": "C-type natriuretic peptide (CNP) analogue API targeted at linear growth restoration in paediatric achondroplasia. Indicated for Achondroplasia. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 1480724-61-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Vosoritide (CAS 1480724-61-5) (Purity \u2265 99.0% (HPLC)). Indication: Achondroplasia.", "sku": "AKP-API-15", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Vosoritide (CAS 1480724-61-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "1480724-61-5" } }, { "@type": "ListItem", "position": 166, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 1 mg, Metformin 500 mg & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-1-mg-metformin-500-mg-pioglitazone-15-mg-tablets-akp-170", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-170-glimepiride-1mg-metformin-500mg-pioglitazone-15mg-tablets.webp", "description": "Three-pathway fixed-dose antidiabetic tablet combining 1 mg glimepiride, 500 mg metformin, and 15 mg pioglitazone to simultaneously target insulin secretion, hepatic output, and peripheral resistance. Active: Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg (1 mg + 500 mg + 15 mg). Indication: Refractory Type 2 diabetes mellitus requiring comprehensive fasting and postprandial triple glycemic control.", "sku": "AKP-170", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Triple-Combination Film-Coated Tablets", "activeIngredient": "Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg", "strength": "1 mg + 500 mg + 15 mg" } }, { "@type": "ListItem", "position": 167, "item": { "@type": "Product", "name": "Semax Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/semax-acetate-research-peptide-akp-rp-15", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-15-semax-acetate.webp", "description": "Heptapeptide ACTH(4-7) Pro-Gly-Pro analogue studied for BDNF expression and neurocognitive biochemical research. Research area: Cognition. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 80714-61-0) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Semax Acetate (CAS 80714-61-0) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Cognition.", "sku": "AKP-RP-15", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "80714-61-0" } }, { "@type": "ListItem", "position": 168, "item": { "@type": [ "Product", "Drug" ], "name": "Vardenafil Tablets 10 mg", "url": "https://www.akumaenterprises-pharma.com/product/vardenafil-tablets-10-mg-akp-383", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-383-vardenafil-10mg-tablets.webp", "description": "High-selectivity PDE5 inhibitor tablet (10 mg) formulated for rapid onset and potent cGMP preservation in moderate-to-severe erectile dysfunction. Active: Vardenafil 10 mg (10 mg). Indication: Erectile dysfunction including diabetes-associated and prostatectomy-related vasculogenic ED.", "sku": "AKP-383", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Vardenafil 10 mg", "strength": "10 mg" } }, { "@type": "ListItem", "position": 169, "item": { "@type": [ "Product", "Drug" ], "name": "Somatostatin Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/somatostatin-acetate-peptide-api-akp-api-16", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-16-somatostatin-acetate.webp", "description": "Cyclic 14-amino-acid neurohormone peptide API for acute upper gastrointestinal haemorrhage, pancreatic fistulas, and endocrine tumours. Indicated for GI bleeding, GI fistula, Pancreatitis, Endocrine tumours. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 38916-34-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Somatostatin Acetate (CAS 38916-34-6) (Purity \u2265 99.0% (HPLC)). Indication: GI bleeding, GI fistula, Pancreatitis, Endocrine tumours.", "sku": "AKP-API-16", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Somatostatin Acetate (CAS 38916-34-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "38916-34-6" } }, { "@type": "ListItem", "position": 170, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride Tablets IP 2 mg", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-tablets-ip-2-mg-akp-171", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-171-glimepiride-2mg-tablets.webp", "description": "Once-daily modern sulfonylurea oral hypoglycemic tablet (2 mg) delivering predictable 24-hour fasting and postprandial blood glucose reduction. Active: Glimepiride IP 2 mg (2 mg). Indication: Type 2 diabetes mellitus glycemic control via enhanced endogenous insulin release and peripheral sensitivity.", "sku": "AKP-171", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Uncoated Scored Tablets", "activeIngredient": "Glimepiride IP 2 mg", "strength": "2 mg" } }, { "@type": "ListItem", "position": 171, "item": { "@type": "Product", "name": "Sermorelin Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/sermorelin-research-peptide-akp-rp-16", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-16-sermorelin.webp", "description": "GHRH(1-29) 29-amino-acid peptide analogue utilized in pituitary growth-hormone release mechanism assays. Research area: Muscle. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 86168-78-7) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Sermorelin (CAS 86168-78-7) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Muscle.", "sku": "AKP-RP-16", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "86168-78-7" } }, { "@type": "ListItem", "position": 172, "item": { "@type": [ "Product", "Drug" ], "name": "Vardenafil Tablets 20 mg", "url": "https://www.akumaenterprises-pharma.com/product/vardenafil-tablets-20-mg-akp-384", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-384-vardenafil-20mg-tablets.webp", "description": "High-selectivity PDE5 inhibitor tablet (20 mg) formulated for rapid onset and potent cGMP preservation in moderate-to-severe erectile dysfunction. Active: Vardenafil 20 mg (20 mg). Indication: Erectile dysfunction including diabetes-associated and prostatectomy-related vasculogenic ED.", "sku": "AKP-384", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Vardenafil 20 mg", "strength": "20 mg" } }, { "@type": "ListItem", "position": 173, "item": { "@type": [ "Product", "Drug" ], "name": "Terlipressin Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/terlipressin-acetate-peptide-api-akp-api-17", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-17-terlipressin-acetate.webp", "description": "Vasopressin V1 receptor agonist pro-drug triglycyl-lysine vasopressin API for hepatorenal syndrome and oesophageal variceal bleeding. Indicated for Oesophagogastric variceal bleeding. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 14636-12-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Terlipressin Acetate (CAS 14636-12-5) (Purity \u2265 99.0% (HPLC)). Indication: Oesophagogastric variceal bleeding.", "sku": "AKP-API-17", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Terlipressin Acetate (CAS 14636-12-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "14636-12-5" } }, { "@type": "ListItem", "position": 174, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 2 mg & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-2-mg-pioglitazone-15-mg-tablets-akp-172", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-172-glimepiride-2mg-pioglitazone-15mg-tablets.webp", "description": "Dual-mechanism oral antidiabetic tablet pairing 2 mg glimepiride insulin secretagogue action with 15 mg pioglitazone PPAR-gamma insulin sensitization. Active: Glimepiride 2 mg + Pioglitazone 15 mg (2 mg + 15 mg). Indication: Type 2 diabetes with pronounced insulin resistance uncontrolled on monotherapy.", "sku": "AKP-172", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Combo Tablets", "activeIngredient": "Glimepiride 2 mg + Pioglitazone 15 mg", "strength": "2 mg + 15 mg" } }, { "@type": "ListItem", "position": 175, "item": { "@type": "Product", "name": "Dihexa Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/dihexa-acetate-research-peptide-akp-rp-17", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-17-dihexa-acetate.webp", "description": "Oligopeptide angiotensin IV analogue evaluated in hepatocyte growth factor (HGF/c-Met) synaptogenesis research. Research area: Cognitive disorders. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 1401708-83-5) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Dihexa Acetate (CAS 1401708-83-5) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Cognitive disorders.", "sku": "AKP-RP-17", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "1401708-83-5" } }, { "@type": "ListItem", "position": 176, "item": { "@type": [ "Product", "Drug" ], "name": "Silodosin 8 mg & Dutasteride 0.5 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/silodosin-8-mg-dutasteride-0-5-mg-tablets-akp-343", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-343-silodosin-8mg-dutasteride-0-5mg-tablets.webp", "description": "Combined uroselective alpha-1A adrenoceptor blocker silodosin 8 mg and 5-alpha-reductase inhibitor dutasteride 0.5 mg tablet providing immediate urinary flow relief while progressively shrinking prostate volume. Active: Silodosin 8 mg + Dutasteride 0.5 mg (8 mg + 0.5 mg). Indication: Moderate-to-severe benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).", "sku": "AKP-343", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Silodosin 8 mg + Dutasteride 0.5 mg", "strength": "8 mg + 0.5 mg" } }, { "@type": "ListItem", "position": 177, "item": { "@type": [ "Product", "Drug" ], "name": "Octreotide Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/octreotide-acetate-peptide-api-akp-api-18", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-18-octreotide-acetate.webp", "description": "Somatostatin-mimetic octapeptide API with high receptor affinity for acromegaly, carcinoid syndrome, and VIPoma parenteral vials. Indicated for Acromegaly, Neuroendocrine tumours. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 79517-01-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Octreotide Acetate (CAS 79517-01-4) (Purity \u2265 99.0% (HPLC)). Indication: Acromegaly, Neuroendocrine tumours.", "sku": "AKP-API-18", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Octreotide Acetate (CAS 79517-01-4)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "79517-01-4" } }, { "@type": "ListItem", "position": 178, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 2 mg & Metformin 500 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-2-mg-metformin-500-mg-tablets-akp-173", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-173-glimepiride-2mg-metformin-500mg-tablets.webp", "description": "Foundational dual oral hypoglycemic combination uniting 2 mg glimepiride beta-cell insulin stimulation with 500 mg metformin hepatic glucose-output inhibition. Active: Glimepiride 2 mg + Metformin 500 mg (2 mg + 500 mg). Indication: Type 2 diabetes mellitus poorly controlled on either metformin or sulfonylurea monotherapy.", "sku": "AKP-173", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Bilayer / Film-Coated Tablets", "activeIngredient": "Glimepiride 2 mg + Metformin 500 mg", "strength": "2 mg + 500 mg" } }, { "@type": "ListItem", "position": 179, "item": { "@type": "Product", "name": "TB-500 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/tb-500-research-peptide-akp-rp-18", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-18-tb-500.webp", "description": "Synthetic thymosin beta-4 (Ac-LKKTETQ) peptide studied in actin-sequestering, angiogenesis, and cellular migration models. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 77591-33-4) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: TB-500 (CAS 77591-33-4) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-18", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "77591-33-4" } }, { "@type": "ListItem", "position": 180, "item": { "@type": [ "Product", "Drug" ], "name": "Silodosin Tablets 4 mg", "url": "https://www.akumaenterprises-pharma.com/product/silodosin-tablets-4-mg-akp-344", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-344-silodosin-4mg-tablets.webp", "description": "Prostate-selective alpha-1A adrenoceptor antagonist tablet (4 mg) relaxing prostatic and bladder-neck smooth muscle with minimal orthostatic blood pressure effects. Active: Silodosin 4 mg (4 mg). Indication: Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).", "sku": "AKP-344", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Tablets", "activeIngredient": "Silodosin 4 mg", "strength": "4 mg" } }, { "@type": "ListItem", "position": 181, "item": { "@type": [ "Product", "Drug" ], "name": "Pasireotide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/pasireotide-peptide-api-akp-api-19", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-19-pasireotide.webp", "description": "Multi-receptor somatostatin analogue cyclohexapeptide API active at sst1, sst2, sst3, and sst5 for refractory acromegaly and Cushing's disease. Indicated for Acromegaly. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 396091-73-9) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Pasireotide (CAS 396091-73-9) (Purity \u2265 99.0% (HPLC)). Indication: Acromegaly.", "sku": "AKP-API-19", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Pasireotide (CAS 396091-73-9)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "396091-73-9" } }, { "@type": "ListItem", "position": 182, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 2 mg, Metformin 500 mg & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-2-mg-metformin-500-mg-pioglitazone-15-mg-tablets-akp-174", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-174-glimepiride-2mg-metformin-500mg-pioglitazone-15mg-tablets.webp", "description": "Three-pathway fixed-dose antidiabetic tablet combining 2 mg glimepiride, 500 mg metformin, and 15 mg pioglitazone to simultaneously target insulin secretion, hepatic output, and peripheral resistance. Active: Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg (2 mg + 500 mg + 15 mg). Indication: Refractory Type 2 diabetes mellitus requiring comprehensive fasting and postprandial triple glycemic control.", "sku": "AKP-174", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Triple-Combination Film-Coated Tablets", "activeIngredient": "Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg", "strength": "2 mg + 500 mg + 15 mg" } }, { "@type": "ListItem", "position": 183, "item": { "@type": "Product", "name": "Tesamorelin Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/tesamorelin-research-peptide-akp-rp-19", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-19-tesamorelin.webp", "description": "Stabilized N-terminally modified GHRH(1-44) analogue examined in lipid-metabolism and somatotropic axis assays. Research area: Muscle / Better sleep. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 218949-48-5) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Tesamorelin (CAS 218949-48-5) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Muscle / Better sleep.", "sku": "AKP-RP-19", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "218949-48-5" } }, { "@type": "ListItem", "position": 184, "item": { "@type": [ "Product", "Drug" ], "name": "Tamsulosin HCl (MR) & Dutasteride Tablets", "url": "https://www.akumaenterprises-pharma.com/product/tamsulosin-hcl-mr-dutasteride-tablets-akp-352", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-352-tamsulosin-hcl-mr-dutasteride-tablets.webp", "description": "Synergistic men's urology formulation combining modified-release tamsulosin 0.4 mg smooth-muscle relaxation with dual type-1/type-2 5-alpha-reductase inhibition (dutasteride 0.5 mg). Active: Tamsulosin HCl (MR) 0.4 mg + Dutasteride 0.5 mg (0.4 mg (MR) + 0.5 mg). Indication: Symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostate gland and acute urinary retention risk.", "sku": "AKP-352", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Modified-Release Combo Tablets", "activeIngredient": "Tamsulosin HCl (MR) 0.4 mg + Dutasteride 0.5 mg", "strength": "0.4 mg (MR) + 0.5 mg" } }, { "@type": "ListItem", "position": 185, "item": { "@type": [ "Product", "Drug" ], "name": "Triptorelin Acetate / Pamoate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/triptorelin-acetate-pamoate-peptide-api-akp-api-20", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-20-triptorelin-acetate-pamoate.webp", "description": "High-potency LHRH/GnRH super-agonist decapeptide API available as acetate and sustained-release pamoate salts for prostate oncology. Indicated for Advanced prostate cancer. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 57773-63-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Triptorelin Acetate / Pamoate (CAS 57773-63-4) (Purity \u2265 99.0% (HPLC)). Indication: Advanced prostate cancer.", "sku": "AKP-API-20", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Triptorelin Acetate / Pamoate (CAS 57773-63-4)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "57773-63-4" } }, { "@type": "ListItem", "position": 186, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 1 mg, Metformin HCl 500 mg (SR) & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-1-mg-metformin-hcl-500-mg-sr-pioglitazone-15-mg-akp-175", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-175-glimepiride-1mg-metformin-500mg-sr-pioglitazone-15mg-tablets.webp", "description": "Triple antidiabetic bilayer tablet incorporating sustained-release metformin HCl 500 mg to reduce GI side effects alongside glimepiride (1 mg) and pioglitazone 15 mg. Active: Glimepiride 1 mg + Metformin HCl 500 mg (SR) + Pioglitazone 15 mg (1 mg + 500 mg (SR) + 15 mg). Indication: Uncontrolled Type 2 diabetes mellitus requiring triple therapy with improved GI tolerance.", "sku": "AKP-175", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Triple Tablets", "activeIngredient": "Glimepiride 1 mg + Metformin HCl 500 mg (SR) + Pioglitazone 15 mg", "strength": "1 mg + 500 mg (SR) + 15 mg" } }, { "@type": "ListItem", "position": 187, "item": { "@type": "Product", "name": "Thymosin Alpha-1 (TA-1) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/thymosin-alpha-1-ta-1-research-peptide-akp-rp-20", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-20-thymosin-alpha-1-ta-1.webp", "description": "Acylated 28-amino-acid thymic peptide researched in T-cell maturation, dendritic activation, and toll-like receptor signalling. Research area: Autoimmune / Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 62304-98-7) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Thymosin Alpha-1 (TA-1) (CAS 62304-98-7) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Autoimmune / Recovery.", "sku": "AKP-RP-20", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "62304-98-7" } }, { "@type": "ListItem", "position": 188, "item": { "@type": [ "Product", "Drug" ], "name": "Tamsulosin Hydrochloride Modified Release 0.4 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/tamsulosin-hydrochloride-modified-release-0-4-mg-tablets-akp-353", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-353-tamsulosin-hydrochloride-mr-0-4mg-tablets.webp", "description": "24-hour modified-release uroselective alpha-1A/1D blocker tablet engineered for flat plasma pharmacokinetics, steady urinary relief, and low dizziness incidence. Active: Tamsulosin Hydrochloride MR 0.4 mg (0.4 mg (Modified Release)). Indication: Functional symptoms of benign prostatic hyperplasia (BPH) and impaired urinary flow.", "sku": "AKP-353", "category": "Tablets \u2014 Sexual Wellness Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Modified-Release Tablets", "activeIngredient": "Tamsulosin Hydrochloride MR 0.4 mg", "strength": "0.4 mg (Modified Release)" } }, { "@type": "ListItem", "position": 189, "item": { "@type": [ "Product", "Drug" ], "name": "Goserelin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/goserelin-peptide-api-akp-api-21", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-21-goserelin.webp", "description": "Synthetic GnRH super-agonist decapeptide API designed for subcutaneous implant formulations in hormone-responsive oncology and endometriosis. Indicated for Prostate cancer, Precocious puberty, Endometriosis, Uterine fibroids. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 65807-02-5) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Goserelin (CAS 65807-02-5) (Purity \u2265 99.0% (HPLC)). Indication: Prostate cancer, Precocious puberty, Endometriosis, Uterine fibroids.", "sku": "AKP-API-21", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Goserelin (CAS 65807-02-5)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "65807-02-5" } }, { "@type": "ListItem", "position": 190, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 1 mg, Metformin HCl 500 mg (SR) & Voglibose 0.2 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-1-mg-metformin-hcl-500-mg-sr-voglibose-0-2-mg-ta-akp-176", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-176-glimepiride-1mg-metformin-500mg-sr-voglibose-0-2mg-tablets.webp", "description": "Triple glycemic regimen combining glimepiride 1 mg, sustained-release metformin HCl 500 mg, and alpha-glucosidase inhibitor voglibose 0.2 mg to blunt post-meal carbohydrate absorption spikes. Active: Glimepiride 1 mg + Metformin HCl 500 mg (SR) + Voglibose 0.2 mg (1 mg + 500 mg (SR) + 0.2 mg). Indication: Type 2 diabetes mellitus with pronounced postprandial glucose excursions.", "sku": "AKP-176", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Triple Tablets", "activeIngredient": "Glimepiride 1 mg + Metformin HCl 500 mg (SR) + Voglibose 0.2 mg", "strength": "1 mg + 500 mg (SR) + 0.2 mg" } }, { "@type": "ListItem", "position": 191, "item": { "@type": "Product", "name": "DSIP Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/dsip-research-peptide-akp-rp-21", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-21-dsip.webp", "description": "Delta-sleep-inducing nonapeptide standard investigated in circadian neurobiology and endocrine stress-response assays. Research area: Better sleep. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 62568-57-4) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: DSIP (CAS 62568-57-4) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Better sleep.", "sku": "AKP-RP-21", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "62568-57-4" } }, { "@type": "ListItem", "position": 192, "item": { "@type": [ "Product", "Drug" ], "name": "Glimepiride 2 mg, Metformin HCl 500 mg (SR) & Pioglitazone 15 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/glimepiride-2-mg-metformin-hcl-500-mg-sr-pioglitazone-15-mg-akp-177", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-177-glimepiride-2mg-metformin-500mg-sr-pioglitazone-15mg-tablets.webp", "description": "Triple antidiabetic bilayer tablet incorporating sustained-release metformin HCl 500 mg to reduce GI side effects alongside glimepiride (2 mg) and pioglitazone 15 mg. Active: Glimepiride 2 mg + Metformin HCl 500 mg (SR) + Pioglitazone 15 mg (2 mg + 500 mg (SR) + 15 mg). Indication: Uncontrolled Type 2 diabetes mellitus requiring triple therapy with improved GI tolerance.", "sku": "AKP-177", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Sustained-Release Triple Tablets", "activeIngredient": "Glimepiride 2 mg + Metformin HCl 500 mg (SR) + Pioglitazone 15 mg", "strength": "2 mg + 500 mg (SR) + 15 mg" } }, { "@type": "ListItem", "position": 193, "item": { "@type": [ "Product", "Drug" ], "name": "Degarelix Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/degarelix-peptide-api-akp-api-22", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-22-degarelix.webp", "description": "Third-generation GnRH receptor antagonist decapeptide API achieving immediate testosterone suppression without initial flare in prostate cancer. Indicated for Prostate cancer. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 214766-78-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Degarelix (CAS 214766-78-6) (Purity \u2265 99.0% (HPLC)). Indication: Prostate cancer.", "sku": "AKP-API-22", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Degarelix (CAS 214766-78-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "214766-78-6" } }, { "@type": "ListItem", "position": 194, "item": { "@type": [ "Product", "Drug" ], "name": "Metformin 500 mg & Gliclazide 80 mg Tablets", "url": "https://www.akumaenterprises-pharma.com/product/metformin-500-mg-gliclazide-80-mg-tablets-akp-222", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-222-metformin-500mg-gliclazide-80mg-tablets.webp", "description": "Synergistic dual antidiabetic tablet combining biguanide metformin 500 mg with beta-cell-sparing sulfonylurea gliclazide 80 mg for durable HbA1c control and favorable cardiovascular safety. Active: Metformin 500 mg + Gliclazide 80 mg (80 mg (ER)). Indication: Type 2 diabetes mellitus vascular-protective combination therapy.", "sku": "AKP-222", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Film-Coated Combo Tablets", "activeIngredient": "Metformin 500 mg + Gliclazide 80 mg", "strength": "80 mg (ER)" } }, { "@type": "ListItem", "position": 195, "item": { "@type": "Product", "name": "Gonadorelin Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/gonadorelin-research-peptide-akp-rp-22", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-22-gonadorelin.webp", "description": "Synthetic gonadotropin-releasing decapeptide hormone used as an analytical and endocrine receptor reference standard. Research area: Sex drive. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 33515-09-2) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Gonadorelin (CAS 33515-09-2) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Sex drive.", "sku": "AKP-RP-22", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "33515-09-2" } }, { "@type": "ListItem", "position": 196, "item": { "@type": [ "Product", "Drug" ], "name": "Metformin Hydrochloride Tablets IP 1000 mg", "url": "https://www.akumaenterprises-pharma.com/product/metformin-hydrochloride-tablets-ip-1000-mg-akp-223", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-223-metformin-hydrochloride-1000mg-tablets.webp", "description": "High-strength 1000 mg biguanide antihyperglycemic tablet reducing hepatic gluconeogenesis and improving peripheral insulin sensitivity without hypoglycemia or weight gain. Active: Metformin Hydrochloride IP 1000 mg (1000 mg). Indication: First-line Type 2 diabetes mellitus management, prediabetes, and polycystic ovary syndrome (PCOS) insulin resistance.", "sku": "AKP-223", "category": "Tablets \u2014 Anti-Diabetic Medication", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "High-Strength Film-Coated Tablets", "activeIngredient": "Metformin Hydrochloride IP 1000 mg", "strength": "1000 mg" } }, { "@type": "ListItem", "position": 197, "item": { "@type": [ "Product", "Drug" ], "name": "Cetrorelix Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/cetrorelix-peptide-api-akp-api-23", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-23-cetrorelix.webp", "description": "Potent GnRH antagonist peptide API blocking premature ovulation in assisted reproductive technology (ART) protocols. Indicated for Prevention of premature ovulation in ART. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 120287-85-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Cetrorelix (CAS 120287-85-6) (Purity \u2265 99.0% (HPLC)). Indication: Prevention of premature ovulation in ART.", "sku": "AKP-API-23", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Cetrorelix (CAS 120287-85-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "120287-85-6" } }, { "@type": "ListItem", "position": 198, "item": { "@type": "Product", "name": "CJC-1295 (with / without DAC) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/cjc-1295-with-without-dac-research-peptide-akp-rp-23", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-23-cjc-1295.webp", "description": "Tetrasubstituted GHRH(1-29) research peptide (available for Drug Affinity Complex / Mod GRF 1-29 assay comparisons). Research area: Muscle. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 863288-34-0) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: CJC-1295 (with / without DAC) (CAS 863288-34-0) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Muscle.", "sku": "AKP-RP-23", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "863288-34-0" } }, { "@type": "ListItem", "position": 199, "item": { "@type": [ "Product", "Drug" ], "name": "Carbetocin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/carbetocin-peptide-api-akp-api-24", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-24-carbetocin.webp", "description": "Heat-stable long-acting oxytocin analogue octapeptide API vital for preventing postpartum haemorrhage (PPH) across tropical African maternity settings. Indicated for Postpartum haemorrhage. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 37025-55-1) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Carbetocin (CAS 37025-55-1) (Purity \u2265 99.0% (HPLC)). Indication: Postpartum haemorrhage.", "sku": "AKP-API-24", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Carbetocin (CAS 37025-55-1)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "37025-55-1" } }, { "@type": "ListItem", "position": 200, "item": { "@type": "Product", "name": "Survodutide Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/survodutide-research-peptide-akp-rp-24", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-24-survodutide.webp", "description": "Dual GLP-1 and glucagon receptor agonist peptide researched for hepatic lipid oxidation and energy expenditure pathways. Research area: Metabolic health. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 2805997-46-8) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Survodutide (CAS 2805997-46-8) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Metabolic health.", "sku": "AKP-RP-24", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "2805997-46-8" } }, { "@type": "ListItem", "position": 201, "item": { "@type": [ "Product", "Drug" ], "name": "Atosiban Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/atosiban-peptide-api-akp-api-25", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-25-atosiban.webp", "description": "Competitive oxytocin/vasopressin receptor antagonist nonapeptide API used intravenously to delay imminent preterm birth. Indicated for Inhibition of uterine contractions; delay of preterm birth. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 90779-69-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Atosiban (CAS 90779-69-4) (Purity \u2265 99.0% (HPLC)). Indication: Inhibition of uterine contractions; delay of preterm birth.", "sku": "AKP-API-25", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Atosiban (CAS 90779-69-4)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "90779-69-4" } }, { "@type": "ListItem", "position": 202, "item": { "@type": "Product", "name": "Melanotan I Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/melanotan-i-research-peptide-akp-rp-25", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-25-melanotan-i.webp", "description": "Linear non-selective melanocortin agonist tridecapeptide investigated in melanogenesis and photoprotection studies. Research area: Skincare. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 75921-69-6) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Melanotan I (CAS 75921-69-6) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Skincare.", "sku": "AKP-RP-25", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "75921-69-6" } }, { "@type": "ListItem", "position": 203, "item": { "@type": [ "Product", "Drug" ], "name": "Oxytocin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/oxytocin-peptide-api-akp-api-26", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-26-oxytocin.webp", "description": "USP/EP-grade uterotonic nonapeptide hormone API for sterile labour induction and active postpartum haemorrhage prophylaxis. Indicated for Dystocia / Labour induction. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 50-56-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Oxytocin (CAS 50-56-6) (Purity \u2265 99.0% (HPLC)). Indication: Dystocia / Labour induction.", "sku": "AKP-API-26", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Oxytocin (CAS 50-56-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "50-56-6" } }, { "@type": "ListItem", "position": 204, "item": { "@type": "Product", "name": "Melanotan II Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/melanotan-ii-research-peptide-akp-rp-26", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-26-melanotan-ii.webp", "description": "Cyclic lactam heptapeptide melanocortin receptor agonist studied across MC1R, MC3R, MC4R, and MC5R binding assays. Research area: Sex drive. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 121062-08-6) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Melanotan II (CAS 121062-08-6) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Sex drive.", "sku": "AKP-RP-26", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "121062-08-6" } }, { "@type": "ListItem", "position": 205, "item": { "@type": [ "Product", "Drug" ], "name": "Teriparatide Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/teriparatide-acetate-peptide-api-akp-api-27", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-27-teriparatide-acetate.webp", "description": "Bioactive PTH (1-34) 34-amino-acid peptide API stimulating osteoblastic bone formation in high-fracture-risk osteoporosis. Indicated for Osteoporosis (postmenopausal high fracture risk). Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 52232-67-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Teriparatide Acetate (CAS 52232-67-4) (Purity \u2265 99.0% (HPLC)). Indication: Osteoporosis (postmenopausal high fracture risk).", "sku": "AKP-API-27", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Teriparatide Acetate (CAS 52232-67-4)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "52232-67-4" } }, { "@type": "ListItem", "position": 206, "item": { "@type": "Product", "name": "Aviptadil (VIP) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/aviptadil-vip-research-peptide-akp-rp-27", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-27-aviptadil-vip.webp", "description": "28-amino-acid vasoactive intestinal peptide (VIP) investigated in pulmonary surfactant protection and anti-inflammatory cytokine research. Research area: Anti-inflammatory / Immunomodulation. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 40077-57-4) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Aviptadil (VIP) (CAS 40077-57-4) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Anti-inflammatory / Immunomodulation.", "sku": "AKP-RP-27", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "40077-57-4" } }, { "@type": "ListItem", "position": 207, "item": { "@type": [ "Product", "Drug" ], "name": "Plecanatide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/plecanatide-peptide-api-akp-api-28", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-28-plecanatide.webp", "description": "Uroguanylin analogue 16-amino-acid GC-C agonist peptide API indicated for chronic idiopathic constipation (CIC) and IBS-C. Indicated for CIC. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 467426-54-6) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Plecanatide (CAS 467426-54-6) (Purity \u2265 99.0% (HPLC)). Indication: CIC.", "sku": "AKP-API-28", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Plecanatide (CAS 467426-54-6)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "467426-54-6" } }, { "@type": "ListItem", "position": 208, "item": { "@type": "Product", "name": "Elamipretide (SS-31) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/elamipretide-ss-31-research-peptide-akp-rp-28", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-28-elamipretide.webp", "description": "Mitochondria-targeted cardiolipin-stabilizing tetrapeptide (SS-31 / Elamipretide) examined in oxidative phosphorylation assays. Research area: Mitochondrial dysfunction. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 736992-21-5) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Elamipretide / SS-31 (CAS 736992-21-5) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Mitochondrial dysfunction.", "sku": "AKP-RP-28", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "736992-21-5" } }, { "@type": "ListItem", "position": 209, "item": { "@type": [ "Product", "Drug" ], "name": "Eptifibatide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/eptifibatide-peptide-api-akp-api-29", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-29-eptifibatide.webp", "description": "Cyclic heptapeptide glycoprotein IIb/IIIa platelet aggregation inhibitor API for acute coronary syndrome and angioplasty. Indicated for Acute coronary syndrome. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 188627-80-7) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Eptifibatide (CAS 188627-80-7) (Purity \u2265 99.0% (HPLC)). Indication: Acute coronary syndrome.", "sku": "AKP-API-29", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Eptifibatide (CAS 188627-80-7)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "188627-80-7" } }, { "@type": "ListItem", "position": 210, "item": { "@type": "Product", "name": "Orforglipron Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/orforglipron-research-peptide-akp-rp-29", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-29-orforglipron.webp", "description": "Non-peptide small-molecule GLP-1R agonist research reference compound studied alongside peptide incretin benchmarks. Research area: Metabolic disorders. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 2212020-52-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Orforglipron (CAS 2212020-52-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Metabolic disorders.", "sku": "AKP-RP-29", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "2212020-52-3" } }, { "@type": "ListItem", "position": 211, "item": { "@type": [ "Product", "Drug" ], "name": "Bivalirudin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/bivalirudin-peptide-api-akp-api-30", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-30-bivalirudin.webp", "description": "Synthetic 20-amino-acid direct thrombin inhibitor peptide API indicated for percutaneous coronary intervention (PCI) and HIT anticoagulation. Indicated for Anticoagulation in PCI; Thrombocytopenia, Thromboembolism. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 128270-60-0) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Bivalirudin (CAS 128270-60-0) (Purity \u2265 99.0% (HPLC)). Indication: Anticoagulation in PCI; Thrombocytopenia, Thromboembolism.", "sku": "AKP-API-30", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Bivalirudin (CAS 128270-60-0)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "128270-60-0" } }, { "@type": "ListItem", "position": 212, "item": { "@type": "Product", "name": "SLU-PP-332 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/slu-pp-332-research-peptide-akp-rp-30", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-30-slu-pp-332.webp", "description": "Pan-ERR (estrogen-related receptor \u03b1/\u03b2/\u03b3) agonist research compound utilized in mitochondrial biogenesis pathway studies. Research area: Metabolic health. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 303760-60-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: SLU-PP-332 (CAS 303760-60-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Metabolic health.", "sku": "AKP-RP-30", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "303760-60-3" } }, { "@type": "ListItem", "position": 213, "item": { "@type": [ "Product", "Drug" ], "name": "Icatibant Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/icatibant-acetate-peptide-api-akp-api-31", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-31-icatibant-acetate.webp", "description": "Selective bradykinin B2 receptor antagonist decapeptide API for acute attacks of hereditary angioedema (HAE). Indicated for Hereditary angioedema (HAE). Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 130308-48-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Icatibant Acetate (CAS 130308-48-4) (Purity \u2265 99.0% (HPLC)). Indication: Hereditary angioedema (HAE).", "sku": "AKP-API-31", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Icatibant Acetate (CAS 130308-48-4)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "130308-48-4" } }, { "@type": "ListItem", "position": 214, "item": { "@type": "Product", "name": "Adamax Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/adamax-research-peptide-akp-rp-31", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-31-adamax.webp", "description": "Adamantane-modified Semax derivative heptapeptide researched in neurotrophin induction and neuroplasticity assay panels. Research area: Cognitive disorders. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 12279-41-3) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Adamax (CAS 12279-41-3) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Cognitive disorders.", "sku": "AKP-RP-31", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "12279-41-3" } }, { "@type": "ListItem", "position": 215, "item": { "@type": [ "Product", "Drug" ], "name": "Nesiritide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/nesiritide-peptide-api-akp-api-32", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-32-nesiritide.webp", "description": "Recombinant-equivalent 32-amino-acid B-type natriuretic peptide (BNP) API for acute decompensated congestive heart failure. Indicated for Acute decompensated heart failure. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 124584-08-3) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Nesiritide (CAS 124584-08-3) (Purity \u2265 99.0% (HPLC)). Indication: Acute decompensated heart failure.", "sku": "AKP-API-32", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Nesiritide (CAS 124584-08-3)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "124584-08-3" } }, { "@type": "ListItem", "position": 216, "item": { "@type": "Product", "name": "SS-31 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ss-31-research-peptide-akp-rp-32", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-32-ss-31.webp", "description": "D-Arg-dimethylTyr-Lys-Phe-NH2 mitochondria-targeting tetrapeptide (Szeto-Schiller 31) for cellular bioenergetics research. Research area: Recovery. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 736992-21-5) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: SS-31 (CAS 736992-21-5) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Recovery.", "sku": "AKP-RP-32", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "736992-21-5" } }, { "@type": "ListItem", "position": 217, "item": { "@type": [ "Product", "Drug" ], "name": "Angiotensin II Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/angiotensin-ii-peptide-api-akp-api-33", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-33-angiotensin-ii.webp", "description": "Endogenous vasoconstrictor octapeptide API formulated for distributive shock and refractory hypotension resuscitation. Indicated for Shock and hypotension. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 4474-91-3) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Angiotensin II (CAS 4474-91-3) (Purity \u2265 99.0% (HPLC)). Indication: Shock and hypotension.", "sku": "AKP-API-33", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Angiotensin II (CAS 4474-91-3)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "4474-91-3" } }, { "@type": "ListItem", "position": 218, "item": { "@type": "Product", "name": "Ibutamoren Mesylate (MK-677) Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ibutamoren-mesylate-mk-677-research-peptide-akp-rp-33", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-33-ibutamoren-mesylate-mk-677.webp", "description": "Non-peptidic spiroindoline growth hormone secretagogue (MK-677) research reference compound for GHS-R1a assay calibration. Research area: Growth hormone deficiency. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 159752-10-0) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Ibutamoren Mesylate (MK-677) (CAS 159752-10-0) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Growth hormone deficiency.", "sku": "AKP-RP-33", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "159752-10-0" } }, { "@type": "ListItem", "position": 219, "item": { "@type": [ "Product", "Drug" ], "name": "Thymalfasin Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/thymalfasin-peptide-api-akp-api-34", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-34-thymalfasin.webp", "description": "Synthetic 28-amino-acid thymic peptide immunomodulator API used as a viral-hepatitis therapy and vaccine adjuvant. Indicated for Chronic hepatitis B; vaccine adjuvant. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 69440-99-9) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Thymalfasin (CAS 69440-99-9) (Purity \u2265 99.0% (HPLC)). Indication: Chronic hepatitis B; vaccine adjuvant.", "sku": "AKP-API-34", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Thymalfasin (CAS 69440-99-9)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "69440-99-9" } }, { "@type": "ListItem", "position": 220, "item": { "@type": "Product", "name": "AHK-Cu Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ahk-cu-research-peptide-akp-rp-34", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-34-ahk-cu.webp", "description": "Ala-His-Lys tripeptide copper(II) complex examined in dermal follicle dermal-papilla proliferation and antioxidant studies. Research area: Skincare (Copper Peptide). Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 682809-81-0) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: AHK-Cu (CAS 682809-81-0) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Skincare (Copper Peptide).", "sku": "AKP-RP-34", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "682809-81-0" } }, { "@type": "ListItem", "position": 221, "item": { "@type": [ "Product", "Drug" ], "name": "Teduglutide Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/teduglutide-peptide-api-akp-api-35", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-35-teduglutide.webp", "description": "DPP-IV-resistant GLP-2 analogue 33-amino-acid peptide API stimulating intestinal mucosal adaptation in short bowel syndrome. Indicated for Short bowel syndrome. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 197922-42-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Teduglutide (CAS 197922-42-2) (Purity \u2265 99.0% (HPLC)). Indication: Short bowel syndrome.", "sku": "AKP-API-35", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Teduglutide (CAS 197922-42-2)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "197922-42-2" } }, { "@type": "ListItem", "position": 222, "item": { "@type": "Product", "name": "ARA-290 Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/ara-290-research-peptide-akp-rp-35", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-35-ara-290.webp", "description": "Non-erythropoietic 11-amino-acid EPO helix-B surface peptide (cibinetide) researched in innate repair receptor tissue protection. Research area: Wound repair / Neuromodulation. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 1208243-50-8) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: ARA-290 (CAS 1208243-50-8) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Wound repair / Neuromodulation.", "sku": "AKP-RP-35", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "1208243-50-8" } }, { "@type": "ListItem", "position": 223, "item": { "@type": [ "Product", "Drug" ], "name": "Ziconotide Acetate Peptide API", "url": "https://www.akumaenterprises-pharma.com/product/ziconotide-acetate-peptide-api-akp-api-36", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-api-36-ziconotide-acetate.webp", "description": "N-type calcium channel blocker 25-amino-acid conotoxin peptide API for intrathecal management of severe refractory chronic pain. Indicated for Severe chronic pain. Supplied as lyophilized crystalline powder (Purity \u2265 99.0% HPLC, CAS 107452-89-1) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Active: Ziconotide Acetate (CAS 107452-89-1) (Purity \u2265 99.0% (HPLC)). Indication: Severe chronic pain.", "sku": "AKP-API-36", "category": "Peptides \u2014 Pharmaceutical Peptide APIs", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "dosageForm": "Lyophilized Peptide API", "activeIngredient": "Ziconotide Acetate (CAS 107452-89-1)", "strength": "Purity \u2265 99.0% (HPLC)", "mpn": "107452-89-1" } }, { "@type": "ListItem", "position": 224, "item": { "@type": "Product", "name": "Pinealon Acetate Research Peptide", "url": "https://www.akumaenterprises-pharma.com/product/pinealon-acetate-research-peptide-akp-rp-36", "image": "https://www.akumaenterprises-pharma.com/product-images/products/akp-rp-36-pinealon-acetate.webp", "description": "Neuroprotective synthetic tripeptide (Glu-Asp-Arg) evaluated in neuronal oxidative stress and synaptic gene-expression research. Research area: Age-related cognitive decline. Supplied as pure lyophilized vial (Purity \u2265 99.0% HPLC, CAS 2703745-42-8) with batch HPLC & Mass Spectrometry CoA. Strictly for In-Vitro Laboratory & Research Use Only (RUO). Active: Pinealon Acetate (CAS 2703745-42-8) (Research Grade \u00b7 Purity \u2265 99.0% (HPLC)). Indication: Preclinical & In-Vitro Research \u2014 Age-related cognitive decline.", "sku": "AKP-RP-36", "category": "Peptides \u2014 Research Peptides (RUO)", "brand": { "@type": "Brand", "name": "Akuma Enterprise Pharma" }, "offers": { "@type": "Offer", "priceCurrency": "USD", "price": "0.00", "availability": "https://schema.org/InStock", "priceValidUntil": "2027-12-31" }, "manufacturer": { "@type": "Organization", "name": "Akuma Enterprise Pharma Pvt. Ltd." }, "mpn": "2703745-42-8" } } ] }